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Background: Over 80 million adults in the United States have hypertension (~33%); of those, less
than half are adequately controlled. Regular participation in exercise is one of the most important
modifiable risk factor in the prevention, treatment, and control of hypertension. The antihypertensive
effects of exercise have been studied extensively, concluding that aerobic exercise training (AET)
and dynamic resistance training (RT) lowers blood pressure (BP) 5-7 and 2-3 mmHg among adults
with hypertension. Nonetheless, BP reductions with AET and RT (~1-9 and ~0-6 mmHg) vary
widely, highlighting the significant variability in the training response. Patient and exercise
characteristics may explain these differences; however, what patient profile and exercise features
elicits optimal BP benefit remains unclear. Therefore, we performed two high-quality meta-analyses
that adhered to contemporary standards to determine the effectiveness of AET and RT as stand-alone
antihypertensive therapy and identify what patient profile and exercise ‘dose’ elicited optimal
antihypertensive therapy. Methods: Electronic databases identified 84 and 64 controlled AET (105
interventions) and RT (71 interventions) trials that involved adults ≥19yr and reported BP pre- and
post-intervention. Analyses followed random-effects assumptions. Results: Participants were White,
middle-aged, overweight adults with prehypertension. Moderate-to-vigorous intensity AET and
moderate-intensity RT performed ~3-4 d·wk-1 for 14-18 wks reduced systolic BP (SBP)/diastolic BP
(DBP) ~4/3 mmHg and ~3/2 mmHg versus controls (ps<0.01). Greater BP reductions occurred
among AET and RT samples with higher resting BP: ~7/6 and ~6/5 mmHg for hypertension, ~5/4
and ~3/3 mmHg for prehypertension, ~3/1 and ~0/1 mmHg for normal BP (ps≤0.03). For AET, BP
was reduced to the greatest extent among non-White samples with hypertension that achieved the
largest fitness gains and performed the highest volumes of AET (-12.0/-12.2 mmHg), twice the
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magnitude observed for White samples (-6.8/-6.3 mmHg). Similarly, dynamic RT reduced BP to the
greatest extent among non-White samples with hypertension (-14.3/-10.3 mmHg), reductions
approximately twice the magnitude previously reported following AET. Discussion: These results
highlight the critical need for more precise exercise prescriptions that maximize the effectiveness of
AET and RT as viable stand-alone or combined antihypertensive therapeutic exercise options among
racially/ethnically diverse samples with hypertension.
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Chapter 1
Introduction
1.1 Background and Significance
Cardiovascular disease (CVD) causes 17.3 million global deaths annually, which represents
approximately one-third (~30%) deaths worldwide [1, 2]. CVD-mortality follows a similar pattern in
the United States (US). It is responsible for one of every three US deaths (~76 million) making it one
of the leading causes of mortality [2]. In 2013, over 40% of all CVD-related deaths were attributed to
high blood pressure (BP) [2]. In addition to hypertension, approximately 85% of US adults have at
least one other CVD risk factor [3].
Hypertension is a major risk factor for CVD [2]. Hypertension leads to an estimated 9.4
million annual deaths worldwide, which is about as many deaths that result from all infectious
diseases combined [1]. Nearly ~33% (80 million) of US adults currently have hypertension (systolic
BP [SBP] ≥140 mmHg or diastolic [DBP] ≥90 mmHg) [2]; ~6% higher than the Healthy People 2020
goal of 26.9% of US adults with hypertension [4, 5]. By 2030, this number is projected to reach
41.1%, an increase in hypertension prevalence of 8.4% [2, 4]. Another 68 million US adults
(~36.3%) have prehypertension (SBP 120-139 mmHg or DBP 80-89 mmHg) [2], and are at increased
risk for developing hypertension, incident stroke, myocardial infarction, and CVD [2, 6]. If
prehypertension is left untreated it will progress rapidly to hypertension [2, 7]. The residual lifetime
risk for developing hypertension is 90%, making it one of the most prevalent, modiﬁable, and costly
CVD risk factors [2]. In 2011, the direct and indirect cost of hypertension totaled $46.4 billion.
Based on the current trends, in 2030 these costs are expected to reach ~$274 billion in total medical
expenditures [2].
Over the last decade (1999-2012), hypertension treatment (77% versus 60%) and control
(52% versus 32%) in the US have improved, whereas hypertension prevalence has remained
unchanged (30-32%) [4]. Several modifiable risk factors have been identified in the prevention,
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treatment, and control of hypertension, an important one being regular participation in exercise [2, 4,
7-10]. Lifestyle-related factors were recently identified as the only modifiable determinants of
hypertension [4]; therefore, more intensive efforts should be focused on promoting these strategies to
reduce the significant public health burden of hypertension [2].
1.2 Exercise Recommendations for Hypertension: The Frequency, Intensity, Time and Type of
the Exercise Prescription
Many randomized control trials (RCTs) have investigated the antihypertensive effects of
exercise, and in turn, over 33 meta-analyses have been published to date [11, 12]. Collectively, these
meta-analyses concluded that aerobic training (AET) lowers blood pressure (BP) 5-7 mmHg [9, 13,
14], while dynamic resistance training (RT) lowers BP 2-3 mmHg [9, 14-17] among adults with
hypertension. Accordingly, the American College of Sports Medicine (ACSM) [9] and other
professional organizations and committees [8, 10, 18-20] recommend 30-60 minutes of moderate
intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days of the week [8-10,
18, 20] supplemented by moderate-intensity dynamic RT on ≥2 days∙week-1 [8, 9, 20] for the
prevention, treatment, and control of hypertension.
1.3 The Meta-Analytic Evidence Regarding the Antihypertensive Effects of Exercise
Despite the general consensus that exercise, particularly AET, lowers resting BP, a more
recent and critical review of this literature revealed considerable variability in the magnitude of the
BP reductions following both AET (i.e., 1-9 mmHg) [12] and dynamic RT (i.e., 0-6 mmHg) [9, 16,
21, 22] for reasons that are not clear [8, 12]. Investigators conducting RCTs often report aggregatelevel data with standard deviations exceeding the mean BP change of the sample [23]. Furthermore,
~20-25% of individuals do not lower BP with exercise [24, 25], highlighting the significant intervariability in the BP response to exercise training [9, 26, 27].
Reasons for inter- and intra-individual variability are not well understood but may be
partially attributable to differences in baseline sample and exercise intervention characteristics such

2

as the Frequency, Intensity, Time or Type or FITT of the exercise prescription (Ex R x). Nonetheless,
few meta-analyses have documented significant moderation patterns pertaining to these
characteristics with the exception of resting BP or BP status (i.e., normal, prehypertension and
hypertension) [13, 28-40]. The absence of moderation patterns in the exercise and hypertension
literature may be attributed to earlier meta-analyses [29, 36-38, 41, 42] being underpowered to
perform moderator analysis due small samples (<10 trials), or because meta-analyses have used
statistical approaches that lack the sensitivity to detect exercise-related changes in BP.
More recent meta-analyses [13, 28, 30, 31, 43, 44] with a greater number of included trials
(≥28 trials) do not bear this limitation. In addition, the authors of more recent meta-analyses have
also had access to standard reporting guidelines [45-47] and to more sophisticated meta-analytic
techniques to estimate the exercise-related changes in BP. Theoretically, more recent meta-analyses
should be able to calculate and combine effect size estimates from different studies more precisely
and investigate heterogeneity to a greater extent [47-49]. Conventional meta-analytic techniques,
such as meta-regression, and more complex analyses using multiple moderator models and the
moving constant technique should be able to more accurately quantify the influence of sample and
FITT characteristics and their interaction on resting BP [11, 50-55]. Furthermore, the moving
constant technique can be used to estimate BP effects at different moderator levels to provide greater
clinical translation [54].
It is clear that the science of meta-analysis has continued to grow and become more advanced
[48, 49]. Taken together, it is reasonable to assume carefully conducted meta-analyses that pursue
higher quality methods (e.g., Preferred Reporting Items for Systematic Reviews and Meta-analyses or
PRISMA [56]) should be able to identify what sample characteristics and ‘dose’ of exercise yields
the greatest antihypertensive benefits. Yet, the majority of meta-analyses evaluating the
antihypertensive effects of exercise still fail to fulfill the requirements of the PRISMA reporting
checklist [11, 56-58] which in turn, threatens the validity and clinical translation of their findings.
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1.3.1 Reporting Standards for Meta-Analyses
Systematic reviews and meta-analyses often serve as pillars of scientific statements, exercise
recommendations, and clinical guidelines [56-58]. Therefore, progressively more rigorous standard
reporting practices have been published to improve the overall quality of meta-analyses, focusing on
the consistency and transparency of reporting procedures [45, 46, 59-62]. The QUality Of Reporting
Of Meta-analyses (QUOROM) statement was first published in 1999 [45], and has been updated
twice since then: with the PRISMA Statement in 2009 [46], and more recently with the 2015
PRISMA-P Statement [56, 63].
Johnson and colleagues [11] recently reviewed the methodological quality of 33 published
meta-analyses that examined the effects of exercise on BP. They found more recent meta-analyses
achieved higher quality scores, but none completely satisfied contemporary quality standards [11].
The majority of meta-analyses did not provide adequate information related to their search methods
or duplicate efforts for study selection and data extraction. Further, few meta-analyses documented
the scientific quality of included trials, how study quality interacted with their findings, or discussed
the scientific quality of the included studies in relation to their conclusions [11, 55, 61, 64].
Departure from these contemporary reporting standards [47, 56, 63] may contribute further to the
poor understanding of how important moderators, in particular the sample clinical characteristics, the
‘dose’ of exercise (i.e., FITT of the Ex Rx), and other study features influence the antihypertensive
effects of exercise.
1.4 The Blood Pressure Response to Aerobic Exercise Training
Approximately 27 meta-analyses have examined the effects of AET on resting BP [11].
Given the volume of data, the ACSM classified the BP lowering effects of AET as Category A level
of evidence, meaning there was “overwhelming data from RCTs provided a consistent pattern of
findings regarding the effects of AET on resting BP” [9]. On average, the participants in these metaanalyses were White, middle-aged men and women with prehypertension who performed AET 3
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days·week-1 for 40 min·session-1 at 65% of maximal oxygen consumption (VO2max) for 16 weeks.
This dose of aerobic exercise reduced BP 2-3 mmHg among samples with normal BP and 5-7 mmHg
among samples with hypertension [9].
Although these meta-analyses confirmed that the greatest antihypertensive benefits are
experienced by samples with higher baseline BP, they have not consistently identified other
moderation patterns, nor have they completely satisfied contemporary quality standards [11, 46, 64].
Only three meta-analyses to date reported that race/ethnicity [44], age [65], sex/gender [31], and
aspects of the FIT [14, 65] influenced the BP reductions following AET. Whelton and colleagues
[44] found that AET reduced resting SBP/DBP to greater levels among Asian (6/7 mmHg) and Black
(11/3 mmHg) compared to White samples (3/3 mmHg, p<0.05), while Hayashino and colleagues
[65] observed that AET reduced SBP to greater levels among adults aged ≥60 yrs (~5 mmHg) than
<60 yrs (~1 mmHg); and Cornelissen and Smart [31] found that AET was more effective at lowering
resting BP among samples involving all men (3-5 mmHg) than all women (~1 mmHg).
In addition, Hayashino et al. [65] and Cornelissen et al. [31] identified FIT characteristics
that maximized the BP reductions following AET but with conflicting results. Hayashino et al. [65]
reported that greater reductions in BP occurred with longer duration (≥45 min·session-1) AET (~4
mmHg); whereas Cornelissen et al. [31] found shorter duration (30-45 min·session-1) AET to be
more effective (~3-4 mmHg). In addition, Cornelissen and Smart [31] also reported that AET
performed at moderate-to-vigorous than low intensity and <210 min∙week-1 than >210 min∙week-1 of
AET elicited the greatest BP reductions. Unfortunately, meta-analyses have not routinely identified
moderator patterns, and in the few instances that they have, they are not consistent across metaanalyses [9, 11, 12, 24, 26] and in some cases they conflict [14, 65]. Collectively, these limitations
highlight the paucity of evidence to support a more personalized approach to the Ex Rx for adults
with hypertension.
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To date, few meta-analyses have attempted to quantify the level of heterogeneity among
included trials, and rarely have they been able to explain BP variability through moderator analysis
[31, 44, 65]. The inability of meta-analyses to explain inconsistencies in the BP response following
AET may be attributed to the poor reporting of sample and FIT characteristics in the literature itself,
or the limited statistical methods that have been used to investigate heterogeneity. The majority of
meta-analyses have performed moderator analysis using subgroups despite the availability of
conventional meta-analytic techniques (i.e., meta-regression) and more sophisticated approaches that
involve multiple moderator models [53, 66]. Subgroup analysis, a statistical procedure similar to
analysis of variance (i.e., ANOVA), is most appropriate for research questions focused on analyzing
the differences among group means, which may have lacked the sensitivity and precision needed to
detect exercise-related changes in BP [67, 68]. Unlike meta-regression, subgroup analysis does not
allow for multiple moderators to be examined together [69], and furthermore, it is not suitable for
more complex moderator analysis involving the moving constant technique [54]. The moving
constant technique can estimate BP changes at levels of individual moderators (i.e., sample and FIT
characteristics), to enhance the clinical translation of the findings [54].
In sum, the limitations stated above have precluded a comprehensive meta-analytic
investigation of the antihypertensive effects of AET. Meta-analyzing all of the available literature
using more sophisticated meta-analytic techniques, such as meta-regression and the moving constant
technique, will allow for increased precision in estimating the effect of how sample and FIT
characteristics, and their interactions modulate the BP response to AET.
1.5 The Blood Pressure Response to Dynamic Resistance Training
In the 2004 position stand on exercise and hypertension, the ACSM [9] graded the level of
evidence supporting the BP lowering effects of dynamic RT as Category B, meaning there were “few
randomized trials that existed which are small in size and the results were inconsistent.” Thus, the
ACSM recommends individuals with hypertension perform dynamic RT as a supplement to AET [9].
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At that time, few RCTs had investigated the BP response to dynamic RT and with conflicting results.
The BP lowering effects of dynamic RT were diverse, with BP reductions ranging from ~5-14
mmHg for SBP and ~2-8 mmHg for DBP [70-73]. However, there were also trials that did not report
BP reductions following dynamic RT [70, 72-75], and trials that observed large BP reductions for
both exercise and control groups [70, 72-77]. Furthermore, only two meta-analyses had been
conducted on the BP response to RT [37, 42] that included samples of middle-aged, White men with
normal BP to prehypertension.
Since then, additional RCTs and meta-analyses have been conducted to examine the BP
response to dynamic RT [14-17, 21, 22]. Nonetheless, in contrast to the high-level of evidence
supporting the BP-lowering effects of AET [12], there is much weaker evidence supporting the
efficacy of RT as a viable therapeutic option to lower BP among adults with hypertension that is
primarily based on the findings of six meta-analyses [12, 14-17, 21, 22]. Surprisingly, these metaanalyses included mostly healthy adults with normal BP and prehypertension. Collectively, these
meta-analyses concluded that dynamic RT lowers BP by 2-3 mmHg independent of resting BP
values [9]. However, two meta-analyses by Kelley et al. [21] and Cornelissen et al. [16] reported
larger reductions of 4-6 mmHg, rivaling the magnitude of the reductions reported for individuals with
hypertension following AET [9]. Both Kelley et al. [21] and Cornelissen et al. [16] included the
smallest number of RT trials (~9) and participants (~259 to 290) compared to the previous metaanalyses, that ranged from 11 [15] to upwards of 28 RT trials [14, 17] with samples sizes of 320 [15]
to 1,012 participants [14, 17]. A smaller number of available trials may have resulted in less
precision when estimating the BP lowering effects of dynamic RT.
In contrast to AET, meta-analyses investigation the BP response to dynamic RT have yet to
identify any moderators of the BP changes following dynamic RT. The absence of moderator
variables to date may be attributed to the small number of available trials (~9-25), wide ranges in the
FIT of dynamic RT program, and use of subgroup analysis with categorical variables rather than
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more sophisticated techniques such as meta-regression with continuous variables to investigate
potential moderators. Meta-analysis can be a valuable tool for researchers, especially in small bodies
of literature with disparate results [50, 52, 78, 79]. However, the advantages of meta-analysis over
the primary literature are only realized if proper statistical approaches are undertaken, and
researchers adhere to high quality contemporary standards for conducting and reporting for metaanalyses [11, 56, 61, 64].
Nonetheless, none of the meta-analysis conducted to date have completely satisfied
contemporary methodological study quality standards [11, 56, 64], nor have they been able to
identify important patient or RT characteristics that modulated the BP response to dynamic RT.
Collectively, these observations suggest that the antihypertensive effects of RT may have been
underestimated, and they call into question the generalizability of this weak and limited literature to
adults with hypertension [11, 12].
1.6 Statement of the Problem
Despite the large number of RCTs and meta-analyses that have examined the BP lowering
effects of exercise, little is known about how sample and FITT exercise characteristics may modulate
BP changes following exercise. In general the existing literature supports: 1) BP can be reduced
following AET and dynamic RT but the magnitude of the BP response varies considerably across
trials and modality [12]; 2) sample characteristics may account for some of this variability but metaanalyses have yet to adequately analyze these effects [9, 11, 12, 55]; 3) the ‘dose’ of exercise or FITT
characteristics may also account for some of the variability in the BP response but meta-analyses to
date have not consistently found these variables to influence BP changes following exercise training
[9, 11, 12]; and last, 4) most meta-analyses have not satisfied contemporary standards [11], most
notably, failing to document the study quality of included trials and determine whether quality
independently or interactively influenced their findings [55]. It is possible that low methodological
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quality trials have suppressed dose-response patterns and moderator variables, and these patterns will
emerge more clearly in higher methodological quality trials.
1.7 Specific Aims and Hypotheses
Therefore, this dissertation proposes to perform two meta-analyses that adhere to high
quality, contemporary methodological standards to address the current limitations of the existing
literature:
Specific aim 1: To meta-analyze the existing AET literature with high quality methods to
determine the effectiveness of AET as an antihypertensive therapy and identify what patient clinical
and AET characteristics elicit optimal antihypertensive BP benefit.
Hypothesis 1: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP medication
use, etc.) and AET FIT characteristics will moderate the antihypertensive effects of AET.
Alternative Hypothesis 1: Patient clinical and AET FIT characteristics will not moderate the
antihypertensive effects of AET.
Specific aim 2: To meta-analyze the existing dynamic RT literature with high quality
methods to determine the effectiveness of RT as stand-alone antihypertensive therapy and identify
important moderators (i.e., patient clinical and RT FIT characteristics) of the BP response to provide
insight into the optimal dose of RT to lower BP among adults with hypertension.
Hypothesis 2: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP medication
use, etc.) and RT FIT characteristics will moderate the antihypertensive effects of dynamic RT and
provide insight into the optimal dose of RT as stand-alone antihypertensive therapy for adults with
hypertension
Alternative Hypothesis 2: Patient clinical and RT FIT characteristics will not moderate the
antihypertensive effects of dynamic RT.
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1.8 Clinical Significance
In total, over 33 meta-analyses have been published to date [11, 12]. Collectively, these metaanalyses included primarily White middle aged men and women adults with normal BP to stage-1
hypertension and variables related to race/ethnicity and BP medication use were poorly reported.
Meta-analyses concluded that exercise training can lower BP among adults with normal to stage-1
hypertension but that the magnitude of BP reductions were specific to modality: AET can lower BP
2-3 mmHg among individuals with normal BP and 5-7 mmHg among individuals with hypertension
[9, 13, 14], and dynamic RT can lower BP ~1-3 mmHg, independent of resting BP values [9, 14-17].
It is clear that BP reductions vary widely by modality, however, the influence of sample or FITT
characteristics or their interaction on resting BP are still poorly understood [31, 44, 65].
There is little meta-analytic evidence to support that sample characteristics (i.e., age,
sex/gender, race/ethnicity, antihypertensive medication use, etc.) influence the BP response to
exercise [9]. Therefore the ACSM [9] recommends a generic Ex R x of primarily aerobic exercise
most days of the week supplemented by dynamic RT 2-3 days·week-1 to treat, prevent, and control
hypertension. However, ~20-25% of individuals do not lower BP with exercise [24, 25], and there is
considerable individual variability in this response [9, 23-26]. Reasons for inter- and intra-individual
variability are not clear but suggest that an individualized approach to the Ex R x for individuals with
hypertension may provide greater antihypertensive effects than the current recommendations do.
Nonetheless, meta-analyses to date have contributed little to our understanding of how important
moderators, in particular the sample clinical characteristics, the ‘dose’ of exercise (or FITT), and
other study features influence the antihypertensive effects of exercise. Knowledge of these features
can, in turn, better inform exercise guidelines and recommendations regarding the antihypertensive
effects of exercise for policy makers, health care providers, and exercise professionals and increase
the clinical utility of and adherence to exercise as an antihypertensive lifestyle therapy.
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Abstract
Aerobic exercise training (AET) is recommended as antihypertensive lifestyle therapy because it
lowers blood pressure (BP) 5-7 mmHg among most adults with hypertension. Yet due to significant
inter-variability in the BP response to AET, it is unclear what types of patient populations would
benefit most from AET as antihypertensive therapy. The purpose of our meta-analysis was to identify
what patient and exercise features elicit the largest BP benefits. Electronic databases identified 84
controlled AET trials (105 interventions) that involved adults ≥19 yr and reported BP pre- and postAET. Analyses followed random-effects assumptions. Participants (n=3,634) were White (18% nonWhite), middle-aged (47.9±12.9yr), overweight (27.6±3.3 kg·m-2) adults with prehypertension
(systolic BP [SBP]/diastolic BP [DBP]: 130.8±12.7/81.6±9.0 mmHg). AET performed at moderateto-vigorous intensity (5.9±1.7 metabolic equivalents [MET]) for 44.4±23.7 min·session-1, 3.5±1.1
d·wk-1 for 18.3±16.6 wks reduced SBP (d+=-0.37; 95% CI: -0.48, -0.27; -3.5 mmHg) and DBP
(d+= -0.35; 95% CI: -0.45, -0.24; -2.7 mmHg) compared to control. Greater BP reductions occurred
among samples with higher resting BP: ~7/6 mmHg for hypertension, ~5/4 mmHg for
prehypertension, and ~3/1 mmHg for normal BP (p=0.033/0.019 SBP/DBP, respectively). Moderateto-vigorous intensity AET conferred the greatest BP reductions among non-White samples with
hypertension that achieved the largest physical fitness gains and performed the highest volumes of
AET (-12.0 mmHg, 95% CI: -15.1, -8.7/-12.2 mmHg, 95% CI: -15.5, -8.9), reductions nearly twice
that observed for White samples (-6.8 mmHg, 95% CI: -9.4, -4.2/-6.3 mmHg, 95% CI: -8.8, -3.7).
These results highlight that critical need for more precise exercise prescriptions that maximize the
effectiveness of AET as antihypertensive therapy for certain patient populations.

Key words: Blood Pressure; Hypertension; Lifestyle Intervention; Systematic Review
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Introduction
Hypertension is the most prevalent, modiﬁable, and costly cardiovascular disease risk factor
(CVD) [1]. Aerobic exercise training (AET) is universally recommended as first line
antihypertensive lifestyle therapy due to the strong level of evidence supporting it lowers blood
pressure (BP) 5-7 mmHg among most adults with hypertension [2]. Therefore, the American College
of Sports Medicine [2] and other professional organizations and committees [3-7] recommend 30-60
minutes of moderate intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days
of the week for the prevention, treatment, and control of hypertension. Nonetheless, the resultant BP
reductions from these recommendations range widely from 1-9 mmHg [8], highlighting the
significant inter-variability in the BP response to AET [2, 9, 10].
Over 33 meta-analyses have been conducted to summarize the antihypertensive effects of
exercise, of which 27 have focused on AET [11]. None of these meta-analyses completely satisfied
contemporary quality standards [11-13], and most failed to identify whether patient (i.e., resting BP,
race/ethnicity, sex/gender, etc.) or aerobic exercise characteristics (i.e., the Frequency, Intensity, and
Time or FIT) modulated the BP response to AET. Only three meta-analyses to date have reported that
race/ethnicity [14], sex/gender [15], age [16], and aspects of the FIT [16, 17] influenced the BP
reductions following AET, and these three meta-analyses each found different patterns. For example,
Whelton and colleagues [14] found that AET reduced resting systolic BP (SBP)/diastolic BP (DBP)
to greater levels among Asian (6/7 mmHg) and Black (11/3 mmHg) compared to White samples (3/3
mmHg, p<0.05), while Hayashino and colleagues [16] observed that AET reduced SBP to greater
levels among adults aged ≥60 yrs (~5 mmHg) than <60 yrs (~1 mmHg), and Cornelissen and Smart
[15] reported that AET reduced BP to a greater extent among samples of all men (~3-5 mmHg) than
all women (~1 mmHg). In addition, Hayashino et al. [16] reported greater BP reductions (~4 mmHg)
following longer duration (≥45 min·session-1) AET, whereas Cornelissen et al. [15] found shorter
duration (30-45 min·session-1) AET elicited greater BP reductions (~3-4 mmHg).
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Despite the strong level of evidence to support the antihypertensive effects of AET, there is
significant inter- and intra-variability in the magnitude of reported BP reductions that result from
AET ranging from 1-9 mmHg [8, 11], and meta-analyses have been unable to identify consistent
patterns in what patient and exercise features result in optimal BP benefit. Reasons for these
discrepancies are not clear, but may partially reside in the fact the volume of available literature is
continually increasing, or the inability of past meta-analyses to adequately explore high levels of
heterogeneity that arise from combining trials with widely varying sample and exercise intervention
characteristics.
Therefore, we performed a meta-analysis that adhered to high-quality contemporary
standards with the primary purpose of identifying what patient clinical and AET characteristics are
associated with the greatest antihypertensive therapeutic BP benefit.
Methods
This study fully satisfies the criteria implied by the PRISMA Statement (Preferred Reporting
Items for Systematic Review and Meta-Analyses) [18, 19] and AMSTAR Methodological Quality
Scale (Assessment of Multiple SysTemAtic Reviews) [13, 20].
Inclusion Criteria
Included reports satisfied four a priori inclusion criteria: (1) involved adult participants ≥19
yr [21-23]; (2) followed a controlled study design comparing AET to a non-exercise, non-diet control
or comparison group; (3) reported pre-and post-intervention BP for the AET and the control/
comparison groups; and (4) reported the FIT of the AET intervention. Trials were excluded if they
involved populations with diseases unrelated to CVD (i.e., cancer survivors, substance abusers,
human immunodeficiency virus, or AIDS) or if they involved participants using weight loss drugs,
diet therapy, or diet modifications.
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Search Strategy
Aided by a medical librarian at the University of Connecticut (JL), we systematically
searched several electronic interfaces from their inception until January 31, 2014 using a Boolean
search strategy. Potential qualifying reports were retrieved from the following electronic databases:
Cumulative Index to Nursing and Allied Health Literature, PubMed (including Medline), Scopus
(including EMBASE), SportDiscus, and Web of Science (see Appendix 1 for the complete search
strategy). The reference lists of included studies and relevant meta-analyses and reviews were also
manually searched for additional reports. After retrieving all potentially qualifying reports, duplicate
records were removed, and three investigators (HVM, TUG, LML) screened the sample for inclusion
with duplication of effort.
Approximately 2,000 potentially relevant reports were reviewed for eligibility. Of these, we
identified 84 controlled trials that satisfied the inclusion criteria (See Appendix 2 for the reference
list of included studies). Six trials compared the antihypertensive effects among men versus women
[24, 25], pre- versus post-menopausal women [26], and samples with normal BP versus
prehypertension [27] and hypertension [28, 29], yielding 90 independent AET interventions. Eleven
trials compared >1 AET interventions to a single control group (i.e., non-independent comparisons)
that included: lower versus higher AET intensity [30-32], frequency (days∙week-1) [33] or duration
(min∙session-1) [34]; arm versus leg cycle ergometer [35], walking versus fitness [36], and group
versus home-based AET performed at various intensities [25], yielding 105 total AET interventions
(Figure 1 shows the systematic search and selection process for included AET trials).
Data Extraction and Coded Variables
All coded variables were extracted using a standardized coding form and coder manual that
was previously developed by a team of experts (LSP, BTJ, TBHM) and pilot tested. Two trained
coders (HVM, TUG) independently extracted and entered the study information with high reliability
across all dimensions (mean Cohen’s κ=0.82 for categorical variables [37]; mean Pearson’s r=0.90
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for continuous variables); all disagreements were resolved by discussion. Coded variables included:
(1) study characteristics (e.g., publication year, study location or region, primary study outcome); (2)
experimental study design (e.g., single versus multiple AET interventions, between or within-group
design, level of supervision); (3) sample clinical characteristics (e.g., baseline BP, age, race/ethnicity,
sex/gender, BP medication use); and (4) features of the AET intervention including the FIT.
Included trials rarely disclosed the race/ethnicity of their study participants (only 18% did)
[25, 34, 38-50]. When unreported, we estimated race/ethnicity based on the study location [51].
Samples were considered “White” when the study was conducted in North America, Europe and
Australia; “Asian” when conducted in Asian countries; “Hispanic and/or Latino” when conducted in
South America; and “Black” when conducted in African countries.
Methodological Study Quality Assessment
Included trials were assessed for methodological study quality using a modified version of
the Downs and Black Checklist [52, 53] (see Appendix 3 for the augmented checklist). This
instrument [54] is well validated in the health science literature and has been shown to be valid and
reliable in assessing RCTs and non-RCTs. The Downs and Black Checklist [54] addresses five
subscales of methodological quality: (1) reporting, (2) external validity, (3) bias, (4) confounding,
and (5) power, making it one of the most comprehensive extant instruments to evaluate study quality
[55]. Methodological study quality score was gauged as the percentage of items satisfied out of a
possible 29-point total. A similar approach was used to evaluate each study quality subscale, which
provided a summary of the methodological strengths and weaknesses for each study. Consistent with
other reviews [52, 53], ranges in overall methodological study quality scores were grouped into three
quality levels: low (≤14 points, <50%), moderate (>14 to 23 points, 50-79%), and high (≥24 points,
≥80%). In addition to quantifying the overall quality of the AET literature, we examined how overall
study quality (or individual quality items) influenced the BP response to AET independently or
interactively [56] with other moderators.
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Study Outcomes, Effect Size Calculation, and Moderator Analyses
The standardized mean difference effect size (d) was used to quantify the effectiveness of
AET as antihypertensive therapy, defined as the magnitude of change in resting SBP and DBP postversus pre-intervention, correcting for small sample size bias and baseline differences [57, 58].
Whenever possible, multiple comparisons were disaggregated for trials with more than one AET and
control intervention groups [24-29] and analyzed as individual studies [59] (i.e., independent
comparisons) (see Appendix 4.1 for effect size estimations). However, several trials compared two
[30, 31, 34-36, 45, 60, 61] and three [25, 32] AET interventions to a single control group (i.e., nonindependent comparisons), to control for the dependency among our effect sizes (i.e., multiple AET
interventions compared to a single control [62]), we used the within-group effect size estimate for all
moderator analyses, i.e., AET and control groups were treated as separate observations (see
Appendix 4.2 for effect size estimations). Negative d values indicated greater BP reductions were
observed at post- compared to pre-intervention; the magnitude of the mean difference can be
interpreted as -0.20, -0.50, and -0.80 for small, medium and large reductions in resting BP [63]. Last,
we provided the equivalent BP change in mmHg as a supplement to the observed d in order to
enhance the clinical relevance of our findings (see Appendices 4.3 and 4.4 for the methods used to
calculate the raw metric in mmHg).
We used Stata 13.1 (StataCorp, College Station, TX) [64] with macros for meta-analysis [59]
to perform all statistical analyses, incorporating random-effects assumptions. We visually examined
funnel plots for any asymmetries in the effect size distribution to identify potential publication or
other reporting biases [65], in addition to performing statistical tests of bias using Begg [66] and
Egger [67] methods. Publication bias was detected using Begg's (SBP: z=-3.13, p=0.002 and DBP:
z=-3.40, p=0.001) but not Egger’s (SBP: t=-1.76, p=0.081 and DBP: t=-1.53, p=0.128) tests. After
adjusting for suspected publication bias using the Duval and Tweedie trim and fill technique [68],
our results remained significant and with high levels of heterogeneity for SBP (Q=358.2, p<0.001;
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I2=66.7%, 95% CIs: 59.8%, 72.5%) and DBP (Q=297.2, p<0.001; I2=63.7%, 95% CIs: 55.4%,
70.4%) [69, 70] (see Appendix 11, Figure S1, for the publication bias results, unadjusted and
adjusted funnel plots via the trim and fill technique). However, it is important to note that these tests
assume a single population of effect sizes and may inaccurately identify publication bias when
significant heterogeneity is present [65, 71]. Moreover, asymmetries can also result from other
biases, such as clinical heterogeneity and (poor) study quality [67, 72, 73].
Inconsistencies in d values were estimated with the I2 statistic and its confidence intervals
(95% CIs) [70, 74]. I2 values range from 0% (homogeneity) to 100% (greater heterogeneity). As I2
increases, homogeneity is less likely and heterogeneity is more likely; a CI that does not include 0%
indicates that the hypothesis of homogeneity is rejected, and an inference of heterogeneity is merited
[70, 75].
Moderator analyses were used to explain variability in ds for SBP and DBP, using weighted
regression models with maximum likelihood estimation of the random-effects weights, the inverse of
the variance for each d. Continuous moderators were mean centered and categorical variables were
contrast coded before generating interaction terms or examining multiple moderators simultaneously
[56, 76]. Significant moderators identified with bivariate meta-regression analyses were combined in
multiple moderator models for SBP and DBP and examined simultaneously to explain unique study
variance. In each multiple moderator model, the moving constant technique [76] was used to estimate
the magnitude of weighted mean effect sizes (

) and their CIs at different levels of interest for

individual moderators that represented a range of observations, including minimum and maximum
values while statistically controlling for the presence of moderators. For both SBP and DBP, an
additive model was generated from the final model that represented the greatest potential
antihypertensive benefit that could be achieved with AET. Individual moderators and interaction
terms were evaluated simultaneously at the level that conferred the greatest BP benefit (i.e., greatest
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BP reductions), which in turn, demonstrated the combination of patient and AET characteristics that
elicited optimal antihypertensive therapy. Finally, the proportion of between-study variance
explained by the model (i.e., Multiple R) and the residual unexplained variance (i.e., I2 Residual) are
provided (see Model Summary for Tables 2 and 3). Summary statistics are presented as Mean ±
standard deviation (M ± SD) unless otherwise stated. Two-sided statistical significance was p<0.05.
Results
Study Characteristics
AET interventions were published between 1976 and 2013 (2000±9 yr), and conducted in
North America (51.4%, k=54), Europe (29.5%, k=31), Asia (9.5%, k=10), Africa (3.8%, k=4),
Australia (2.9%, k=3), and South America (2.9%, k=3). Among the trials that reported sex/gender
(three trials did not), 16 and 31 trials involved all women (18.4%) or all men (35.6%), respectively;
the remaining trials involved samples of mixed sex/gender (46.0%, k=40). The majority of AET
interventions were RCTs (80%, k=84) and received financial support from at least one source
(73.3%, k=77), yet less than half examined BP as a primary study outcome (46.7%, k=49). Most
RCTs (84.5%) used a parallel (i.e., between-subject) study design (k=71), six interventions [30, 38,
77-79] used a within-subject, cross-over design, and small proportion of RCTs involved a “placebo”
comparison group instead of a non-exercise or ‘wait-listed’ control. In total, 10 AET trials used
“placebo” or “active control” that included: stretching/flexibility exercises 3 days·wk-1 [47, 80-83],
low intensity exercise [29, 84] or yoga [85] 2-3 days·wk-1, weekly health education lectures [86], or a
once-daily supplement (i.e., sugar pill) [87].
[INSERT FIGURE 1]
Included interventions achieved “moderate” or “fair” quality on average (64.5% of items
satisfied) [52, 53], although methodological study quality scores varied widely (41.4-86.2%).
(Appendix 5 summarizes the overall methodological study quality for the AET sample and how well
AET interventions satisfied individual quality items). Trials were most likely to satisfy the reporting
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(77.5%±13.4%), internal validity-bias (70.0%±9.6%), and internal validity-confounding
(62.6%±21.0%) quality subscales, but were least likely to satisfy external validity (49.6%±40.7) and
power (1.7%±11.7%). None of the individual quality subscales emerged as significant moderators of
the BP response to AET. Finally, only two trials satisfied ≥80% of the Downs and Black study
quality checklist items (83.6%±2.8%) [38, 77]. (Appendix 6 in describes the overall and itemized
methodological study quality for each of the included AET trials).
Sample Characteristics
Baseline sample characteristics were similar between the AET (n=2,200) and non-exercise
control (n=1,434) groups (p>0.05). Overall, participants (n=3,634) were sedentary (97%), middleaged (47.9±12.9 yr), overweight (27.6±3.3 kg·m-2) adults with prehypertension (SBP/DBP:
130.8±12.7/ 81.6±9.0 mmHg). The included interventions had mostly White (80%, k=72) samples
(n=2,995), with 20% comprising a “non-White” sample: 11% (k=10) Asian (n=391) [41, 50, 78, 8894], 6% (k=5) African American (n=169) [45, 47, 49, 95, 96], and 3% (k=3) Hispanic/Latino (n=79)
[80-82]. Approximately 13% (n=472) of the AET sample was on antihypertensive medication, but
nearly half of AET trials failed to disclose BP medication use (58% did). Almost all of the AET
interventions (88%, k=92) assessed physical fitness before and after AET, of which ~69% (k=73) did
so via maximal or peak oxygen consumption expressed relative to body weight (58%, k=61)
(ml∙kg∙min-1) or in absolute units (11%, k=12). Table 1 provides additional details regarding the
different assessment techniques used to quantity fitness (see Table 1 footnote). To accommodate
various physical fitness measurements, we examined the percent change in fitness after versus before
AET (% change=[FitnessPost─Pre ⁄FitnessPre ]×100%). Collectively, AET and control samples had
poor physical fitness levels at baseline (29.0±8.1 ml∙kg∙min-1) [97]; non-White (22.7±5.0
ml∙kg∙min-1) were lower than White samples (29.7±7.7 ml∙kg∙min-1) (p<0.001). Overall, AET
significantly improved physical fitness compared to baseline values (~17%); fitness gains were larger
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among non-White (19.5%±12.4%) than White samples (16.2%±14.8%) (p<0.001). In addition to
improved physical fitness, the AET group reduced body weight, body mass index and body fat
percent compared to baseline values (ps<0.001); the percent change from baseline was greater
following AET versus control for body weight (-1.4%, p<0.01), body fat percent (-3.4%, p<0.01),
and body mass index (-1.3%, p=0.05) (see Appendix 7 for a summary of select characteristics
evaluated post- versus pre-intervention for AET and control groups).
[INSERT TABLE 1 HERE]
Aerobic Exercise Training Intervention Characteristics
AET was performed at moderate-to-vigorous intensity (5.9±1.7 metabolic equivalents
[MET]) for 44.4±23.7 min∙session-1, 3.5±1.1 days∙week-1 for 18.3±16.6 weeks. Most AET programs
involved walking (26%), cycling (24%), or combinations of walking with cycling, jogging or running
(23%). (See Appendix 8 for a general description of the AET and control intervention
characteristics). Overall, AET programs were within the recommended AET volume range of ≥500‒
1,000 MET∙min∙week-1 (~850 MET∙min∙week-1) [97], with no difference in the exercise volume
performed among White (856.5±411.7 MET∙min∙week-1) and non-White samples (827.8±300.5
MET∙min∙week-1) (p=0.780). Direct supervision was reported in 52% of the AET interventions
(k=55); 14% of interventions used a combination of supervised and unsupervised sessions (k=15),
and 18% of interventions were not supervised (k=19). Finally, samples demonstrated high adherence
to AET completing ~87% of all training sessions, but only 64% reported this detail (Appendix 8).
Resting Blood Pressure Assessment
Overall, included AET trials failed to disclose important details related to the resting BP
assessment. The majority of AET interventions assessed BP manually (53%) or with an automated
monitor (21%) while participants were in a seated (68%) or supine (32%) position, yet one-fourth of
trials did not report these details (See Appendix 9 for the general description of the resting BP
assessment details). A small subset of AET interventions (k=9) assessed ambulatory BP in addition

28

to causal/clinic BP [29, 30, 39, 78, 82, 89, 98, 99], but less than half monitored BP for 24 hours [29,
82, 89]. AET interventions were least likely to disclose the timing of pre-and post-BP assessments:
Only half (52%) reported the duration (minutes) of quiet rest preceding baseline BP assessment, and
even fewer reported (20%) the duration (hours) between the last exercise bout and the final postintervention BP measurement (Appendix 9).
The Antihypertensive Effects of Aerobic Exercise Training
On average, small to moderate reductions in SBP (d+=-0.37; 95% CI: -0.48, -0.27; -3.5
mmHg) and DBP (d+=-0.35; 95% CI: -0.45, -0.24; -2.7 mmHg) were observed following AET
relative to control, whereas moderate to large reductions in SBP (d+=-0.45; 95% CI: -0.53, -0.37; -5.9
mmHg) and DBP (d+=-0.41; 95% CI: -0.49, -0.33; -3.7 mmHg) were observed after versus before
AET only (i.e., within-group weighted mean effect size estimates). Collectively, these effect size
estimates lacked homogeneity. Appendix 10 provides the weighted mean effect sizes and tests for
homogeneity (i.e., Cochran Q [100] and I2 [70, 75] statistics) for SBP and DBP. (See Appendix 12,
Figure S2, for the contour-enhanced funnel plots, i.e., confunnels, for the visual representation of the
effect size distribution for SBP and DBP).
Moderator Analyses
Bivariate meta-regression analyses revealed significant moderators for SBP and DBP related
to sample, AET, and methodological quality characteristics. When combined in a multiple moderator
models, significant bivariate models explained between ~48% and 90% of the observed
heterogeneity in the BP response to AET (see Tables 2 and 3).
Five moderators explained unique variance relating to the effectiveness of AET to reduce
SBP when entered in a multiple regression model, accounting for ~92% of the between-study
variance (see Table 2). Among the AET groups, SBP reductions were greater among samples with
higher resting SBP (p=0.033), which occurred in a dose response fashion: -7.2 mmHg for
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hypertension, -5.0 mmHg for prehypertension, and -3.3 mmHg for normal SBP (ps<0.05). SBP was
also reduced to greater levels among non-White (-4.1 mmHg) than White samples (-2.2 mmHg)
(p=0.044). Furthermore, SBP reductions occurred in a dose-response pattern as a direct function of
physical fitness gains (p=0.026): -8.4 mmHg for large (>25%‒~50%), -5.0 mmHg for moderate
(~25%), and -2.4 mmHg for small (5%) gains (ps<0.05). The greatest SBP reductions occurred
among samples with hypertension that achieved the largest fitness gains (-9.4 mmHg, 95%
CI: -12.0, -6.8), an effect that was significantly greater among non-White (-12.0 mmHg) than White
samples (-6.8 mmHg) (See Table 2, Additive Model).
[INSERT TABLE 2 HERE]
Three moderators explained unique variance relating to the effectiveness of AET to reduce
DBP when entered in a multiple regression model, accounting for ~48% of the between-study
variance (see Table 3). Among the AET groups, DBP reductions were greater among samples with
higher resting DBP (p=0.019), which occurred in a dose response fashion: -6.1 mmHg for
hypertension, -4.3 mmHg for prehypertension, and 1.1 mmHg for normal DBP (ps<0.05). DBP was
also reduced to a greater levels among non-White (-3.0 mmHg) than White samples (-0.4 mmHg)
(p=0.004). The greatest DBP reductions occurred among samples with hypertension that performed
high volumes of AET (~1200 MET·min·week-1) (-9.3 mmHg, 95% CI: -11.9, -6.7), an effect that
was significantly greater among non-White (-12.2 mmHg) than White samples (-6.3 mmHg) (See
Table 3, Additive Model).
[INSERT TABLE 3 HERE]
Discussion
The primary aim of our meta-analysis was to identify what patient and AET characteristics
associated with the greatest antihypertensive therapeutic BP benefits. Consistent with prior metaanalyses [14, 15, 101-104], we found that AET on average reduced BP ~3-4 mmHg compared to
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control (ps<0.001). We also found the BP reductions following AET occurred in dose response
fashion such that greater BP reductions occurred among samples with hypertension (~7/6 mmHg)
followed by prehypertension (~5/4 mmHg), and normal BP (~3/1 mmHg) (ps≤0.033), which is
consistent with a small subset of previously published meta-analyses [15, 103, 105, 106]. However,
our moderator analyses revealed important, new findings that merit further comment.
Our meta-analysis is the first to find greater BP reductions among samples with hypertension
that achieved large fitness gains and performed high volumes of AET, an effect that was more
pronounced among non-White (~12 mmHg) than White (~6-7 mmHg) samples. Our findings indicate
that non-White samples, notably African American (i.e., non- Hispanic Blacks), Asian, and
Hispanic/Latino populations, may benefit the most from the antihypertensive therapeutic benefit of
AET. This finding is important because these patient populations tend to be at disproportionate risk
of the sequela from CVD and other hypertension-related diseases and health conditions [1, 107-109].
Clearly, there is a need for RCTs that examine how different doses of AET influence the BP response
to exercise among patient populations at disproportionate risk of CVD. Thus, more precise exercise
prescriptions can be applied to maximize the effectiveness of AET as antihypertensive therapy for
populations in most need of these benefits [8].
Surprisingly, there is little prior meta-analytic evidence to support that patient and exercise
characteristics influence the BP response to AET [11]. Therefore, the present exercise
recommendations for hypertension of 30-60 min∙day-1 of moderate intensity aerobic exercise on most
days of the week [2-5, 7] are based primarily upon findings from studies of White, middle aged men
and women adults with normal BP to stage-1 hypertension [2, 11]. Yet, ~20-25% of individuals do
not lower their BP by following these recommendations [110, 111], and for the majority that do, the
resultant BP reductions following AET vary considerably (1-9 mmHg) [8]. Accordingly, our metaanalysis that adhered to high-quality methodological, contemporary standards provides insight into
possible reasons for this variability, revealing that AET programs that produced large gains in
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physical fitness and consisted of high exercise volume were the most effective antihypertensive
lifestyle therapy, and the magnitude of the therapeutic BP benefit differed by race/ethnicity. How
these new findings will translate into more precise exercise prescriptions among patient populations
of differing race/ethnicity merits further investigation because the estimates produced with our
additive models indicated that certain people can lower their BP following AET to similar or even
greater magnitude than those reported with antihypertensive medications[112, 113].
To the best of our knowledge, only one other meta-analysis [51] has investigated the
potential impact of race/ethnicity on the BP response to AET, while two meta-analyses found that
AET duration (min·session-1) [16, 17], intensity [15] and volume (min·week-1) [15] moderated the
magnitude of BP reductions following AET. Reasons for our ability to better capture moderator
patterns than prior meta-analyses are not completely clear but may reside in the fact we: (1) adhered
to high quality contemporary, methodological standards [18, 19]; (2) evaluated and quantitatively
incorporated the methodological quality of included AET trial into our analyses [11, 13] under the
assumption that clearer moderation patterns and dose-response functions should be more visible
when methodological deficits across studies are controlled [56]; and (3) applied more sophisticated
approaches, i.e., multiple moderator models [114, 115] and the moving constant technique [76] to
conventional meta-analytic methods (i.e., meta-regression) versus limited subgroup analysis [116,
117]. These techniques, supplemented by our large number of included AET trials (one of the largest
meta-analytic samples to date), enabled us to estimate the influence of individual moderators while
statistically controlling for the presence of others in the model, and to identify novel race/ethnicdependent moderation patterns by generating theoretically-driven interaction terms that provided
greater clinical translation of our findings.
We, along with prior meta-analyses [8, 11, 17], have found this literature to be of “fair to
moderate” methodological quality [52, 53]. In the absence of a higher quality literature, there is the
potential risk of bias or other threats to the validity of our findings. Therefore, it is also noteworthy to
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mention that in addition to study quality, we also examined other sources of potential bias related to
the Downs and Black quality subscales, whether trials had BP-focused outcomes, and if our results
differed based on the publication year, type of trial (i.e., RCT versus non-RCT), or number of
funding sources. We then statistically examined whether these potential biases modulated the BP
response to AET; even when these features were non-significant in bivariate meta-regression models,
we incorporated them (when possible) to control for confounding or suppression effects that could
arise from lower-quality trials [11, 56]. We found that higher study quality was associated with trials
that were: published more recently (r=0.15, p=0.033), were RCTs (versus non-RCTs) (r=0.36,
p<0.001), adequately powered to detect BP outcomes (Downs and Black Checklist Item 28) (r=0.26,
p=0.087), and received greater amounts of funding support (r=0.12, p=0.096). Interestingly, trials
that received greater funding support were also adequately powered (r=0.67, p<0.001) and tended to
follow standard protocols/established guidelines when measuring BP (i.e., American Heart
Association Council on High BP Research Part 1: Recommendations for BP measurement in Humans
[118]) (r=0.12, p=0.099). Not surprisingly, trials that used standard protocols/established guidelines
for BP assessment had BP-focused primary outcomes (r=0.22, p=0.002) and reported more reliable
and accurate BP assessment methods (Downs and Black Checklist Item 21) (r=0.19, p=0.006). By
examining the potential bias from several sources and incorporating them into our multiple
moderator models (i.e., study quality, trial type, funding support) we can be more confident in our
study results despite the number of methodological deficits and inconsistencies we have documented
in this literature.
Our meta-analysis also identified patient profiles that may benefit the most from AET as
antihypertensive therapy. In agreement with Whelton et al. [51] we found that greater BP reductions
occurred among African American/Hispanic (~10/5 mmHg; k=9) and Asian (~9/6 mmHg; k=10)
compared to White (~5/3 mmHg; k=86) samples (ps<0.034). We also found that the greatest BP
reductions occurred among samples with hypertension that achieved the largest gains in physical
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fitness, an effect that was more pronounced among non-White (~12 mmHg) than White (~7 mmHg)
samples.
Although we are not the first to report that the magnitude of BP reductions were directly
related to improvements in fitness [101, 103, 104, 119], we are the first to document its interaction
with race/ethnicity. Differences in cardiorespiratory fitness levels have been documented across
racial/ethnic groups, in particular that African American [120-122] and South Asian [123, 124]
populations have lower fitness levels compared to Whites. In support of these reports, we found that
cardiorespiratory fitness before AET was lower among non-White than White samples (22.8 versus
29.5 ml·kg·min-1, p=0.006). The exact mechanisms accounting for racial/ethnic differences in fitness
levels are not fully understood, but may be related to these populations simply being more physically
inactive [120-122, 125-127], in addition to greater vascular dysfunction [109, 120, 128, 129] related
to elevated levels of inflammatory [130], oxidative stress and vasoconstrictive factors [128, 131].
AET has been shown to improve endothelial function and reverse vascular damage through repeated,
chronic bouts of increased shear stress and by modifying other CVD risk factors [132-134], but these
improvements are largely dependent on the level of dysfunction prior to AET [129, 132, 133, 135].
Interestingly, we observed greater reductions in pulse pressure, an indicator of vascular health, after
versus before AET among non-White (-7.9%) versus White (-3.4%) samples (p<0.001). Changes in
pulse pressure were also moderately correlated with baseline fitness (r=0.27, p=0.006), such that
greater reductions were observed among those with low physical fitness levels (i.e., non-White
samples).
We also found that higher volumes of AET (~1200 MET·min·week-1) elicited the greatest BP
benefit among adults with hypertension, ranging from ~6-12 mmHg among White and non-White
samples, respectively. Cornelissen and Smart [15] recently reported that AET lasting 30-45
min·session-1, performed at moderate-to-vigorous than low intensity, and lower exercise volumes
(<210 versus >210 min∙week-1) were most effective at reducing BP. Unfortunately, the authors were
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unable to comment on how these FIT characteristics may interact with each, or with patient clinical
characteristics, due to the limitations of subgroup analysis. Our meta-analysis did not bear the same
limitations. When we examined the FIT components and their interaction term (i.e., exercise
volume=Frequency × Intensity × Time) simultaneously, their individual effects were no longer
significant. Our findings support the current exercise volume recommendations for healthy adults
(500-≥1000 MET·min·week-1), except that higher volumes of exercise appear more efficacious
among non-White samples as antihypertensive lifestyle therapy. It is important to note that in our
meta-analysis high volumes of exercise were achieved with more rigorous intensity AET (~8 MET)
performed on 3-5 days·week-1 for 30-40 min·session-1, rather than combinations of AET consisting
of lower intensity, high frequency (>5 days·week-1) and longer duration (>40 min·session-1).
Despite the significant volume of exercise and hypertension literature, to date meta-analyses
have contributed little to our understanding of what patient characteristics and AET ‘dose’ confers
the greatest therapeutic BP benefit. In agreement with the current exercise recommendations for
hypertension, we found that 18 weeks of moderate-to-vigorous AET performed 3-4 days·week-1 for
~40 min·session-1 reduced resting BP ~6-7 mmHg among adults with hypertension (Table S6). Yet,
we observed even greater reductions among samples that achieved large gains in physical fitness and
performed higher volumes of AET, an effect that was greatest among non-White samples.
Nonetheless, ~80% of our sample was considered White, AET interventions used various methods to
assess physical fitness (only ~58% reported VO2peak), and features of the AET intervention were
inconsistently reported (i.e., AET intensity, level of supervision, adherence, etc.) so that the optimal
FIT AET prescription for hypertension and for what populations it may work best as antihypertensive
therapy has yet to be fully elucidated.
Even though we examined several sources for potential biases, of which some addressed the
validity of the BP assessment methods used, it important to reinforce the poor reporting of these
variables in the existing literature. Several reviews [2, 8, 11, 111] have commented on how the level
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of reporting and quality of BP assessment procedures may contribute to the discrepancies observed
across studies in the magnitude of the BP reductions following AET (i.e., unaccounted sources of
heterogeneity). Yet, 38% of AET interventions failed to disclose any BP assessment procedures,
while ~20-30% of AET trials failed to report specific details that included: the type of BP monitor or
assessment tool (76% did), the body position during the BP measurement (72% did), and the timing
of BP measurements at baseline (61% did) and post-intervention (17% did). At this time, it is unclear
how the poor reporting and variability in these parameters influenced our results.
In summary, our meta-analysis that adhered to high-quality methodological, contemporary
standards confirmed that AET is effective antihypertensive therapy for adults with hypertension.
Furthermore, we revealed that AET programs that produced large fitness gains and consisted of high
exercise volume maximized the effectiveness of AET as antihypertensive therapy, most notably for
non-White samples. These results indicate that the present exercise recommendations for
hypertension should be revisited to include more precise exercise prescriptions for patient
populations of differing race/ethnicity who are at disproportionate CVD risk. Our findings indicate a
compelling need for additional RCTs to investigate what combinations of patient and AET
characteristics elicit optimal antihypertensive lifestyle benefit.
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Table 1. Summary of the baseline sample characteristics for the aerobic exercise training
(k=105) and control (k=90) groups.
AET (n=2,200)
Control (n=1,434)
Characteristics
k
Mean ± sd
Range
k
Mean ± sd
Range
Women (%)
101
41.7 ± 38.1
0.0, 100.0
84
40.5 ± 37.8
0.0, 100.0
Age (years)
105
47.9 ± 12.8
20.1, 72.0
85
47.8 ± 13.0
21.6, 72.0
BP Medication Use (%)
75
12.0 ± 24.7
0.0, 100.0
53
12.5 ± 22.6
0.0, 100.0
CVD risk factors/ presence
101
29.6 ± 45.6
0.0, 100.0
53
12.5 ± 22.6
0.0, 100.0
of disease (%)
Race/Ethnicity (%) *
White
86
81.9%
n=1,849
72
80.0%
n=1,146
Asian
10
9.5%
n=223
10
11.1%
n=168
African American/Black
6
5.7%
n=91
5
5.6%
n=78
Hispanic/Latino/Caribbean
3
2.9%
n=37
3
3.3%
n=42
Sedentary (%)
105
97.4 ± 15.2
0.0, 100.0
90
97.3 ± 15.0
0.0, 100.0
Body Composition
Body Weight (kg)
79
78.8 ± 10.4
53.4, 102.4
65
78.2 ± 11.4
53.3, 107.3
Body Mass Index (kg∙m-2)
79
27.4 ± 3.2
21.9, 35.4
63
27.6 ± 3.5
20.3, 37.2
Body Fat (%)
29
30.4 ± 7.4
22.0, 49.6
27
30.4 ± 7.4
22.0, 49.6
Resting Hemodynamics
Systolic BP (mmHg)
105 130.7 ± 12.7 101.2, 167.6
89 130.8 ± 12.7 101.2, 160.0
Diastolic BP (mmHg)
101
81.7 ± 9.0
63.0, 102.0
85
81.5 ± 9.1
58.0, 102.0
MAP (mmHg)
101
98.1 ± 10.0
78.3, 123.5
85
98.1 ± 9.9
74.0, 120.0
Pulse Pressure (mmHg)
101
49.2 ± 6.9
35.0, 77.5
85
49.8 ± 7.3
35.0, 77.5
Heart Rate (beats∙min-1)
12
71.1 ± 3.8
65.0, 75.0
12
71.3 ± 7.6
59.8, 84.0
Physical Fitness †
92
87.6%
65
72.2%
VO2max/VO2peak
61
28.8 ± 7.4
14.5, 45.7
43
29.4 ± 8.2
14.3, 49.4
(ml∙kg∙min-1)
VO2max (L∙min-1)
12
1.7 ± 1.0
0.3, 3.1
8
1.6 ± 1.0
0.3, 3.0
6MWT/SWT (m)
4
583.3 ± 55.4 504.6, 631.0
3
521.5 ± 33.4 500.0, 560.0
Note. Descriptive statistics are presented as Mean ± standard deviation (sd) unless otherwise stated; Range=
Minimum, Maximum. k=the number of observations. Abbr. AET=Aerobic exercise training. BP=Blood
pressure. CVD= Cardiovascular disease. MAP=Mean arterial pressure. VO2max=Maximal oxygen uptake.
VO2peak=Peak oxygen uptake. 6MWT=Six minute walk test. SWT=Shuttle walk test. * Ethnicity/Race was
reported in 16 interventions: White (76-100%) [25, 34, 39, 40, 42-44, 46]; African American/Black (100%) [45,
49]; Asian (100%) [41, 50]; or mixed samples (White=50-98%, Black=17-43%, Hispanic=7% or ‘Other’=3%)
[38, 47, 48]. † Other physical fitness assessments: Exercise/ physical work capacity (Watts) [78, 135, 136];
Graded exercise test (min) [137]; Timed 1.5 mile run (min) [138]; Maximal exercise capacity (Metabolic
equivalent unit) [89]; Maximal exercise capacity (Heart rate, beats∙min -1) [92]; Walking activity (km∙day -1 [139]
or steps∙day -1 [140, 141]); 400-m Endurance capacity test (min∙km -1) [142]; Cardiorespiratory endurance index
step test (no units) [94]; Maximal workload (work level) [35]; Physical activity (kcal∙day -1) [98]; Rate pressure
product [143].
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Abstract
Aerobic exercise is recommended as first-line antihypertensive lifestyle therapy due to a strong body
of evidence showing it lowers blood pressure (BP) 5-7 mmHg among adults with hypertension. Due
to weaker evidence showing dynamic resistance training (RT) reduces BP 2-3 mmHg among adults
with hypertension, RT is recommended as adjuvant lifestyle therapy to aerobic exercise training. Yet,
several lines of evidence exist that suggest RT can lower BP to equal to or greater levels than aerobic
exercise. Therefore, we meta-analyzed 64 controlled trials (71 RT interventions) to determine the
efficacy of dynamic RT as stand-alone antihypertensive therapy. Participants (n=2,374) were White
(56%), middle-aged (47.2±19.0 yr), overweight (26.8±3.4 kg∙m -2) adults with prehypertension
(systolic BP [SBP]/diastolic BP [DBP]: 126.7±10.3/76.8±8.7 mmHg); with 17% on antihypertensive
medication. Overall, moderate-intensity dynamic RT was performed 2.8±0.6 days·week-1 for
14.4±7.9 weeks and elicited small-to-moderate reductions in SBP (d+=-0.31, 95%
CIs: -0.43, -0.19; -3.0 mmHg) and DBP (d+=-0.30, 95% CIs: -0.38, -0.18; -2.1 mmHg) compared to
controls (ps<0.001). Greater BP reductions occurred among samples with higher resting BP: ~6/5
mmHg for hypertension, ~3/3 mmHg for prehypertension, and ~0/1 mmHg for normal BP
(p=0.001/0.023 for SBP/DBP, respectively). Furthermore, BP reductions approximately double the
magnitude of those reported following aerobic exercise training occurred among non-White samples
with hypertension (-14.3 mmHg, 95% CIs: -19.0, -9.4/-10.3 mmHg, 95% CIs: -14.5, -6.2). Our
results indicate that for adults with hypertension, notably non-White samples, dynamic RT may be as
or even more effective than aerobic exercise in lowering BP. RT should be further investigated as a
viable stand-alone therapeutic exercise option for adults with hypertension.

Key words: Blood Pressure; Exercise; Hypertension; Strength Training; Systematic Review
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Introduction
Hypertension is the most prevalent, modiﬁable and costly risk factor for cardiovascular
disease (CVD) [1]. Hypertension leads to an estimated 9.4 million annual deaths worldwide, which is
about as many deaths that result from all infectious diseases combined [2]. Nearly ~33% (80 million)
of US adults currently have hypertension [1]; and by 2030, this number is projected to reach 41.1%
[1, 3]. Lifestyle-related factors are the only modifiable determinants of hypertension [3]; therefore,
more intensive efforts should be focused on promoting these strategies to reduce the significant
public health burden of hypertension [1].
Many randomized control trials (RCTs) have investigated the antihypertensive effects of
exercise, and in turn, over 33 meta-analyses have been published to date [4, 5]. Collectively, these
meta-analyses concluded that aerobic training lowers blood pressure (BP) 5-7 mmHg [6-8], while
dynamic resistance training (RT) lowers BP 2-3 mmHg [6, 8-11] among adults with hypertension.
Accordingly, 30-60 min∙day-1 of moderate-intensity aerobic exercise is recommended on most days
of the week [6, 12-15] supplemented by moderate-intensity dynamic RT on ≥2 days∙week-1 [6, 12,
14] to prevent, treat and control hypertension. Yet, a more critical review of this literature revealed
considerable variability in the magnitude of the BP reductions following both aerobic exercise
training (i.e., 1-9 mmHg) [5] and dynamic RT (i.e., 0-6 mmHg) [6, 10, 16, 17], for reasons that are
not clear [5, 12].
In contrast to the high-level of evidence supporting the BP-lowering effects of aerobic
training [5], there is much weaker evidence supporting the efficacy of RT as a viable therapeutic
option to lower BP among adults with hypertension that is primarily based on the findings of six
meta-analyses [5, 8-11, 16, 17]. Surprisingly, these meta-analyses included mostly healthy adults
with normal BP and prehypertension. Furthermore, none of these meta-analysis completely satisfied
contemporary methodological study quality standards [4, 18, 19], nor were they able to identify
important patient or RT characteristics that modulated the BP response to dynamic RT. Collectively,
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these observations suggest that the antihypertensive effects of RT may have been underestimated,
and they call into question the generalizability of this weak and limited literature to adults with
hypertension [4, 5].
Furthermore, several primary level RT studies have shown that the resultant BP reductions
following dynamic RT may be comparable to that of aerobic training among adults with hypertension
[20-29]. Mota and colleagues [29] found that 16 weeks of moderate-intensity dynamic RT reduced
BP ~14/4 mmHg among 32 older women with controlled hypertension. In another study, Moraes et
al. [30] found that 12 weeks of moderate-intensity RT reduced BP ~16/12 mmHg among 15 middleaged men with hypertension. Moraes et al. concluded that dynamic RT performed three days per
week was effective as stand-alone antihypertensive therapy. A limited number of controlled trials
have directly compared the effectiveness of aerobic training versus RT as antihypertensive therapy
[21-23, 26, 31-34]. Yet, most of these trials found that aerobic exercise training and dynamic RT
lowered systolic BP (SBP)/diastolic BP (DBP) to similar levels among adults with untreated (~7/6
mmHg [22]; 14/8 mmHg [21]) and controlled (~10/3 mmHg) hypertension [23, 26]. BP reductions of
this magnitude following RT have also been observed among young (~9-15/6-8 mmHg) [31, 32, 35]
and middle-aged (~8-10/5-7 mmHg) [33, 34, 36] adults with prehypertension.
Therefore, the purposes of our meta-analysis are to determine the efficacy of dynamic RT as
stand-alone antihypertensive therapy, and identify potential moderators of the BP response to provide
insight into the optimal dose of RT to lower BP among adults with hypertension.
Methods
This study fully satisfies the criteria implied by the PRISMA Statement (Preferred Reporting
Items for Systematic Review and Meta-Analyses) [19, 37] and AMSTAR Methodological Quality
Scale (Assessment of Multiple SysTemAtic Reviews) [18, 38].

55

Inclusion Criteria
Included reports satisfied four a priori inclusion criteria: (1) involved adult participants (≥19
yrs) [39-41]; (2) followed a controlled study design comparing dynamic RT to a non-exercise, nondiet control or comparison group; (3) reported pre-and post-intervention BP for the RT and the
control/comparison groups; and (4) reported the Frequency, Intensity, and Time (or FIT) of the RT
intervention. Trials were excluded if they involved populations with diseases unrelated to CVD (i.e.,
cancer survivors, substance abusers, human immunodeficiency virus or AIDS) or if they involved
participants using weight loss drugs, diet therapy, or diet modifications.
Search Strategy
Aided by a medical librarian at the University of Connecticut (JL), we systematically
searched several electronic interfaces from their inception until January 31, 2014 using a Boolean
search strategy. Potential qualifying reports were retrieved from the following electronic databases:
Cumulative Index to Nursing and Allied Health Literature, PubMed (including Medline), Scopus
(including EMBASE), SportDiscus, and Web of Science (see Appendix 1 for the complete search
strategy). The reference lists of included studies and relevant meta-analyses and reviews were also
manually searched for additional reports. After retrieving all potentially qualifying reports, duplicate
records were removed, and four investigators (HVM, TUG, KF, LML) screened the sample for
inclusion with duplication of effort.
We identified 64 controlled trials that satisfied the inclusion criteria (See Appendix 13 for the
reference list of included studies). Figure 1 shows the systematic search for potential reports and
selection process of included dynamic RT trials. Seven trials involved ≥1 RT groups comparing:
lower versus high intensity RT [42-45], strength versus power RT [46], elastic band versus aquatic
RT [47], and eccentric versus concentric RT [48], yielding 71 total interventions.
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Data Extraction and Coded Variables
All coded variables were extracted using a standardized coding form and coder manual that
was previously developed by a team of experts (LSP, BTJ, TBHM) and pilot tested. Two trained
coders (HVM, KF) independently extracted and entered the study information with high reliability
across all dimensions (mean Cohen’s κ=0.86 for categorical variables [49]; mean Pearson’s r=0.94
for continuous variables); all disagreements were resolved by discussion. Coded variables included:
(1) study characteristics (e.g., publication year, study location or region, primary study outcome); (2)
experimental study design (e.g., single versus multiple RT interventions, between or within-group
design, level of supervision); (3) sample clinical characteristics (e.g., baseline BP, age, race/ethnicity,
sex/gender, BP medication use); and (4) features of the dynamic RT intervention including the FIT
characteristics.
Included trials rarely disclosed the race/ethnicity of their study participants (only 14% did)
[22, 23, 42, 50-55]. When unreported, we estimated race/ethnicity based on the study location [56].
Samples were considered “White” when the study was conducted in North America, Europe and
Australia; “Asian” when conducted in Asian countries; “Hispanic and/or Latino” when conducted in
South America; and “Black” when conducted in African countries.
Methodological Study Quality Assessment
Included trials were assessed for methodological study quality using a modified version of
the Downs and Black Checklist [57, 58] (see Appendix 3 for the augmented checklist). This
instrument [59] is well validated in the health promotion literature and has been shown to be valid
and reliable in assessing RCTs and non-RCTs. The Downs and Black Checklist [59] addresses five
subscales of methodological quality: (1) reporting, (2) external validity, (3) bias, (4) confounding,
and (5) power, making it one of the most comprehensive extant instruments to evaluate study quality
[60]. Methodological study quality score was gauged as percentage of items satisfied out of a
possible 29-point total. A similar approach was used to evaluate each study quality subscale, which
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provided a summary of the methodological strengths and weaknesses for each study. Consistent with
other reviews [57, 58], ranges in overall methodological study quality scores were grouped into three
quality levels: low (≤14 points, <50%), moderate (>14 to 23 points, 50-79%), and high (≥24 points,
≥80%). In addition to quantifying the overall quality of the dynamic RT literature, we examined how
overall study quality (or individual quality items) influenced the BP response to dynamic RT
independently or interactively [61] with other moderators.
Study Outcomes, Effect Size Calculation, and Moderator Analyses
The standardized mean difference effect size (d) was used to quantify the effectiveness of
dynamic RT as stand-alone antihypertensive therapy, defined as the magnitude of change in resting
SBP and DBP post- versus pre-intervention values, correcting for small sample size bias and baseline
differences[62, 63] (see Appendix 4.1 for effect size estimations). Because our effect size estimate is
in a comparable parameter, d, studies with different experimental designs (i.e., parallel study design
versus within-in subject, cross-over design) were combined to maximize the number of studies in our
sample, thus improving the power of our meta-analysis [64-66]. We disaggregated comparisons for
trials with more than one RT intervention (e.g., high versus low intensity RT) [42-48]; effect sizes
were calculated for each comparison and analyzed as separate studies [67]. To control for nonindependent effect sizes (i.e., RT studies with multiple treatment groups compared to a single control
[68]), we performed alternative analyses using the Metafor package [69] for R [70] that accounted
for these issues and yielded the same pattern of results. For simplicity of interpretation, we report the
maximum likelihood estimation analyses for SBP and DBP. Negative d values indicated that
dynamic RT reduced BP more than the non-exercise control/comparison group; the magnitude of the
mean difference can be interpreted as -0.20, -0.50, and -0.80 for small, medium and large reductions
in resting BP [71]. Last, we provided the equivalent BP change in mmHg as a supplement to the
observed d in order to enhance the clinical relevance of our findings (see Appendix 4.3 for the
methods used to calculate the raw metric in mmHg).
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We used Stata 13.1 (StataCorp, College Station, TX) [72] with macros for meta-analysis [67]
to perform all statistical analyses, incorporating random-effects assumptions. We visually examined
funnel plots for any asymmetries in the effect size distribution to identify potential publication or
other reporting biases [73]. In addition, we tested our data for publication bias using Begg [74] (SBP:
z=-0.46, p=0.64; DBP: z=-1.32, p=0.19) and Egger [75] (SBP: t=-1.30, p=0.20; DBP: t=-1.19,
p=0.24) methods; no publication bias was detected by either test (See Appendix 19, Figure S3, for
the Begg and Egger funnel plots). Inconsistencies in d values were estimated with the I2 statistic and
its confidence intervals (95% CIs) [76, 77]. I2 values range from 0% (homogeneity) to 100% (greater
heterogeneity). As I2 increases, homogeneity is less likely and heterogeneity is more likely; a CI that
does not include 0% indicates that the hypothesis of homogeneity is rejected, and an inference of
heterogeneity is merited [77, 78].
Moderator analyses were used to explain variability in ds for SBP and DBP, using weighted
regression models with maximum likelihood estimation of the random-effects weights, the inverse of
the variance for each d. Continuous moderators were mean centered and categorical variables were
contrast coded before generating interaction terms or examining multiple moderators simultaneously
[61, 79]. Significant moderators identified with bivariate meta-regression analyses were combined in
multiple moderator models for SBP and DBP and examined simultaneously to explain unique study
variance. In each multiple moderator model, the moving constant technique [79] was used to estimate
the magnitude of weighted mean effect sizes (

) and their CIs at different levels of interest for

individual moderators that represented a range of observations, including minimum and maximum
values while statistically controlling for the presence of moderators. For both SBP and DBP, an
additive model was generated from the final model that represented the greatest potential
antihypertensive benefit that can be achieved with dynamic RT. Individual moderators and
interaction terms were evaluated simultaneously at the level that conferred the greatest BP benefit
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(i.e., greatest BP reductions), which in turn, demonstrated the combination of patient and RT
characteristics that elicited optimal antihypertensive therapy. Finally, the proportion of betweenstudy variance explained by the model (i.e., Multiple R) and the residual unexplained variance (i.e., I2
Residual) are provided (see Model Summary for Tables 2 and 3). Summary statistics are presented as
Mean ± standard deviation (M ± SD) unless otherwise stated. Two-sided statistical significance was
p<0.05.
Results
Study Characteristics
RT interventions were published between 1987 and 2013 (2006.7±6.4), and were conducted
in North American (32%, k=23), Asia (24%, k=17), Europe (20%, k=14), South America (17%,
k=12), Australia (6%, k=4), and Africa (1%, k=1). Among the trials that reported sex/gender (two
trials did not), 19 interventions involved all women (26.8%), 20 interventions involved all men
(28.2%), and the remaining trials involved samples of mixed sex/gender (42.3%, k=30). The majority
of RT interventions were RCTs (81.7%, k=58), but only half examined BP as a primary study
outcome (47.9%, k=34). Of these, ~70% of RCTs used a parallel (i.e., between-subject) study design
(k=50), two studies [50, 80] used a within-subject, cross-over design, and nine studies involved a
“placebo” comparison group instead of a non-exercise or ‘wait-listed’ control. “Placebo”
interventions included light/low intensity, full body stretching performed two [81, 82] or three days
per week [26, 28, 83, 84], health education lectures that occurred weekly [27] or once every fourth
week [52], or a supplement (i.e., sugar pill) was taken once daily [85].
[INSERT FIGURE 1]
Included trials achieved “moderate quality” (~63% of items satisfied) [57, 58] despite widely
varying methodological quality scores (41%-85%). (Appendix 14 summarizes the overall
methodological study quality for the RT sample and how well RT interventions satisfied individual
quality items). Trials were most likely to satisfying the reporting (78.6%±10.2%), internal validity-
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bias (70.2%±14.9%) and internal validity-confounding (51.5%±30.1%) quality subscales, but were
least likely to satisfy external validity (46.5%±42.3) and power (9.2%±24.4%). None of the
individual quality subscales emerged as significant moderators of the BP response to dynamic RT.
Finally, only seven trials satisfied ≥80% of the Downs and Black study quality checklist items
(83.3%±1.3%). (Appendix 15 describes the overall and itemized methodological study quality for
each of the included dynamic RT trials).
Sample Characteristics
Dynamic RT (n=1,304) and control participants (n=1,070) were largely healthy (61%, k=43),
sedentary, middle-aged (47.4±19.0 yr), overweight (26.7±3.5 kg·m-2) adults with prehypertension
(SBP/DBP: 126.4±9.4/76.6±8.4 mmHg). Nonetheless, a smaller subset consisted of samples with
CVD risk factors or known disease (27%, k=19) including: type 2 diabetes mellitus (3%, k=2), the
metabolic syndrome (2%, k=1), dyslipidemia (2%, k=1), obesity (5%, k=3), CVD (2%, k=1), or
combinations of chronic diseases and health conditions (15%, k=9). Included RT trials yielded a
diverse sample with 56% (k=40) White (n=1,402) and 44% (k=31) non-White that included: 18%
Hispanic/Latino (n=1,505), 24% Asian (n=521), and 1% African American (n=28). Approximately
17% (n=222) of the RT sample was on antihypertensive medication, but approximately one-third of
RT trials failed to disclose BP medication use (68% did). There were no differences in baseline
sample characteristics between the dynamic RT and control groups (see Table 1).
[INSERT TABLE 1 HERE]
Dynamic Resistance Training Intervention Characteristics
Dynamic RT interventions ranged from six to 48 weeks (14.4±7.9 weeks) and consisted of
two to five sessions·week-1 (2.8±0.6 days·week-1). Dynamic RT was performed at moderate-intensity
or levels of exertion that corresponded to 65-70% of one repetition maximum (% of 1-RM)
(64.7±13.0% of 1-RM). Eleven trials (15.5%) failed to disclose RT intensity, and one used the
OMNI-RT scale (see Appendix 16 for a general description of the RT programs). RT programs
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generally targeted the whole body (91.0%, k=63); four interventions focused on the lower body, and
one involved unilateral, upper body RT. Most RT programs reported using machine weights, free
weights, or a combination of modalities (76.1%, k=54) to train muscles groups of the upper and
lower body; however, RT interventions varied widely in their prescription of acute program variables
(see Appendix 16). In general, RT interventions prescribed 2.8±0.9 sets∙exercise -1 (range: 1-5) of
11.0±3.8 repetitions∙set-1 (range: 5-30) for 7.9±2.9 RT exercises per session (range: 1-16). Direct
supervision was reported in 63% of the RT interventions (k=45), including one-on-one supervision
and small group processes; 10% (k=7) reported a combination of supervised and unsupervised
sessions, and 27% (k=19) of trials failed to disclose the level of supervision. The overall adherence to
the RT intervention was high (92.3%±8.9%), but only 65% reported this detail (Appendix 16).
Resting Blood Pressure Assessment
Overall, included RT trials failed to disclose important details related to the resting BP
assessment. Most RT interventions reported the BP assessment tool (81.7%, k=58); of these, two
trials assessed ambulatory BP in addition to causal/clinic BP [22, 86]. BP measurements were taken
in the seated (42.3%) or supine (26.8%) position, yet ~69% of RT interventions did not report these
details. RT interventions were least likely to disclose the timing of pre-and post-BP assessments:
only half (52.1%) reported the duration (minutes) of quiet rest preceding baseline BP assessment, and
even fewer reported (19.7%) the duration (hours) between the last exercise bout and the final postintervention BP measurement. Appendix 17 provides a general description of the BP assessment
details.
Dynamic Resistance Training as Stand-Alone Antihypertensive Therapy
Small to moderate reductions in SBP (d+=-0.31, CIs: -0.43 to -0.19; -3.0 mmHg) and DBP
(d+=-0.30, CIs: -0.38 to -0.18; -2.1 mmHg) were observed following dynamic RT relative to control;
and collectively, the effect sizes lacked homogeneity (SBP: I2=51%; 95% CIs: 36%-63% and DBP:
I2=35%; 95% CIs: 13%-52%). Appendix 18 provides the weighted mean effect sizes and tests for
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homogeneity (i.e., Cochran Q [87] and I2 [77, 78] statistics) for SBP and DBP. (See Appendix 20,
Figure S4, for the contour-enhanced funnel plots, i.e., confunnels, for a visual representation of the
effect size distribution for SBP and DBP).
Moderator Analyses
Bivariate meta-regression analyses revealed significant moderators for SBP and DBP related
to sample, dynamic RT, and methodological quality characteristics. When combined in multiple
moderator models, significant bivariate models explained ≥50% of the observed heterogeneity in the
BP response to dynamic RT (see Tables 2 and 3).
Five moderators explained unique variance relating to the effectiveness of dynamic RT to
reduce SBP when entered in a multiple regression model, accounting for ~67% of the between-study
variance. SBP reductions were greater among samples with higher resting SBP (p=0.011), which
occurred in a dose response fashion: -5.7 mmHg for hypertension, -3.0 mmHg for prehypertension,
and 0.0 mmHg for normal SBP. SBP was also reduced to a greater extent among Non-White (-4.7
mmHg) than White samples (0.0 mmHg) (p=0.002), and among samples who were not taking BP
medication (-4.3 mmHg) compared to those that were (-0.4 mmHg) (p=0.034). Finally, greater SBP
reductions occurred following RT programs that involved ≥8 versus <8 RT exercises per session (4.4 versus -1.4 mmHg, respectively) (p=0.043) and among trials that had BP-focused primary
outcomes versus those that did not (-3.9 versus -0.8 mmHg, respectively) (p=0.032) (see Table 2).
The greatest SBP reductions occurred among samples with untreated hypertension who performed ≥8
RT exercises per session (-11.8 mmHg, 95% CI: -16.0, -7.4), an effect that was significantly greater
among non-White (-14.3 mmHg) than White samples (-9.2 mmHg) (Table 2, Additive Model).
[INSERT TABLE 2 HERE]
Four moderators explained unique variance relating to the effectiveness of dynamic RT to
reduce DBP when entered in a multiple regression model, accounting for ~50% of the between-study
variance. DBP reductions were greater among samples with higher resting DBP (p=0.023): -5.2
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mmHg for hypertension, -3.3 mmHg for prehypertension, and -1.0 mmHg for normal DBP. DBP was
also reduced to a greater extent among samples who were not taking BP medication (-3.5 mmHg)
compared to those that were (-1.2 mmHg) (p=0.028). Last, greater DBP reductions occurred when
dynamic RT was performed ≥3 versus <3 days∙wk-1 (-4.5 versus -0.9 mmHg, respectively) (p=0.02),
and among trials that achieved lower than higher study quality (-3.7 versus -0.3 mmHg, respectively)
(p=0.019) (See Table 3). The greatest DBP reductions occurred among samples with untreated
hypertension who performed RT on 3 or more days·week-1 (-9.9 mmHg, 95% CI: -13.9, -5.9), an
effect that was slightly more pronounced among non-White (-10.3 mmHg) than White samples (-9.2
mmHg) (Table 3, Additive Model).
[INSERT TABLE 3 HERE]
Discussion
The present meta-analysis aimed to determine the efficacy of dynamic RT as stand-alone
antihypertensive therapy, and to identify potential moderators of the BP response to provide insight
into the optimal dose of RT to lower BP among adults with hypertension. Consistent with prior metaanalyses [6, 8-11], overall, we found that moderate-intensity dynamic RT on average reduced BP ~23 mmHg compared to control (ps<0.001). Importantly, our moderator analyses revealed new findings
that merit further comment. We found the BP reductions following RT occurred in dose response
fashion such that greater BP reductions occurred among samples with hypertension (~6/5 mmHg)
followed by prehypertension (~3/3 mmHg), and normal BP (~0/1 mmHg) (ps≤0.023). Dynamic RT
elicited BP reductions that were comparable to those observed with aerobic exercise training among
adults with hypertension. Furthermore, non-White samples with hypertension achieved even larger
BP reductions, approximately double the magnitude reported following aerobic exercise (~10-14
mmHg). Our results indicate that for adults with hypertension, notably non-White (i.e.,
Hispanic/Latino and Asian) samples, dynamic RT may be as or even more effective than aerobic
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exercise training in lowering BP. Due to the novel nature of our findings, RT should be further
investigated as a viable stand-alone therapeutic exercise option for adults with hypertension.
Presently, 30-60 min∙day-1 of moderate intensity aerobic exercise is recommended on most
days of the week supplemented by dynamic RT on ≥2 days∙wk -1 [6, 12-15] as first-line
antihypertensive therapy to lower BP 5-7 mmHg among adults with hypertension. Dynamic RT is
recommended as adjuvant antihypertensive lifestyle therapy to aerobic exercise training because
there is a weaker body of evidence indicating it lowers BP to lesser levels among adults with
hypertension [5, 8-11, 16, 17]. Yet, our meta-analysis, which that adhered to high-quality
methodological standards, revealed that the magnitude of the BP reductions resulting from dynamic
RT are comparable to or greater than those achieved with aerobic exercise training among adults with
hypertension, particularly for non-White samples. Accordingly, our results indicate that the present
exercise recommendations for hypertension should be revisited to include dynamic RT (in addition to
aerobic exercise) as stand-alone antihypertensive lifestyle therapy.
Our meta-analysis adds other new information to the literature, namely we are the first to
identify important moderators of the BP response to dynamic RT. Our most noteworthy and
clinically relevant finding was that dynamic RT elicited BP reductions in dose-response fashion,
findings that align with those reported for aerobic exercise training [4-6], but not with other metaanalyses examining the BP response to RT. Reasons for the differences observed in our metaanalysis compared others are not completely clear but may reside in the fact that we performed one
of the largest and most comprehensive electronic searches to date, included RCT and non-RCTs, and
identified twice the number of RT interventions involving adults with hypertension (k=8) [20-24, 52,
88, 89] than previously reported (k=4) [8]. Furthermore, the other meta-analyses examined potential
moderators of the BP response to RT using subgroup analysis, which lacks the sensitivity and
precision needed to detect small exercise-related changes in BP [90, 91]. We applied conventional
meta-analytic techniques (i.e., meta-regression) and more sophisticated approaches, i.e., multiple
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moderator models [92, 93] and the moving constant technique [79], which allowed us to estimate BP
changes at different levels of individual moderators (i.e., sample and RT characteristics) and
provided greater clinical translation. Second, we quantitatively incorporated and examined whether
study quality independently [4, 18] or interactively [61] modulated the BP response to dynamic RT.
We found that BP reductions were greater among trials that achieved lower than higher study quality,
although, only seven RT trials [32, 50, 80-82, 94, 95] were considered to be of ‘higher’ quality
satisfying ≥80% of the quality items. We also found that, despite overall quality, greater BP
reductions occurred among trials that had BP-focused primary outcomes versus those that did not.
We, along with prior meta-analyses [8, 11, 17], have found this literature to be of ‘fair to
moderate’ methodological quality [57, 58]. In the absence of a higher quality literature, there is the
potential risk of bias or other threats to the validity of our findings. Therefore, it is also noteworthy to
mention that in addition to study quality, we also examined other sources of potential bias related to
the Downs and Black quality subscales, whether trials had BP-focused outcomes, and if our results
differed based on the publication year, type of trial (i.e., RCT versus non-RCT), number of RT
interventions (i.e., single versus multiple RT groups), or number of funding sources. We then
statistically examined whether these potential biases modulated the BP response to AET; even when
these features were non-significant in bivariate meta-regression models, we incorporated them (when
possible) to control for confounding or suppression effects that could arise from lower-quality trials
[4, 61]. We found that higher study quality was associated with trials that: were published more
recently (r=0.45, p<0.001), were RCTs (versus non-RCTs) (r=0.23, p=0.052), were adequately
powered to detect BP outcomes (Downs and Black Checklist Item 28) (r=0.41, p<0.001), compared
a single-RT intervention to control (versus multiple RT groups) (r=0.22, p=0.069), and followed
standard protocols or established guidelines when measuring BP (i.e., American Heart Association
Council on High BP Research Part 1: Recommendations for BP measurement in Humans [96])
(r=0.24, p=0.045). Not surprisingly, trials that used standard protocols/established guidelines when
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assessing BP also used more reliable and accurate BP assessment methods (Downs and Black
Checklist Item 21) (r=0.76, p<0.001). Interestingly, trials that were adequately powered (Downs and
Black Checklist Item 28) also received greater funding support (r=0.26, p=0.029). By examining the
potential risk of bias from several sources and incorporating them into our multiple moderator
models (i.e., study quality, BP-focused outcomes, number of RT interventions) we can be more
confident in our study results despite the number of methodological deficits and inconsistencies we
have documented in this literature.
Through our moderator analyses, we also addressed other noteworthy gaps in this literature.
No meta-analysis conducted to date has identified features of the exercise intervention that
influenced the BP response to dynamic RT, which in part, may be attributed to the poor disclosure of
important RT intervention features. For example, most of the included trials reported the number of
RT exercises (97% did), sets (94% did) and repetitions (92% did) performed at each session, yet only
half reported the RT intensity as a percentage of 1-RM (~54%), and even fewer trials reported the
duration of rest intervals prescribed between sets and/or exercises (~42%). Because BP increases
proportionally to effort [97], muscle mass activation [98-101], intensity and duration of the set
(especially those performed to failure [98, 101-103]), and decreases during rest intervals when blood
flow is restored to working muscles [97, 101, 104, 105], the omission of specific RT features (i.e.,
acute program variables) adds to the lack of knowledge regarding what RT programs have the most
favorable BP, and more generally, cardiovascular, benefit for adults with hypertension. Furthermore,
one-third of RT programs did not incorporate fundamental strength and conditioning principles [97,
106], such as “progressive overload” (i.e., gradual increase in RT intensity/load; repetitions; RT
volume; or introduction of more complex lifting techniques) (34% did) or “specificity” (28% did).
Indeed, nearly 70% of all trials did not report RT progression (38%) or provided few details
regarding how progression occurred (28%) that replication of the RT prescription is impossible.
Given that training adaptations are specific to the stimulus applied (i.e., principle of specificity), it is

67

troubling that the majority of trials failed to report any rationale or theoretical basis for their RT
program design. Nonetheless, in agreement with the current exercise recommendations for
hypertension, we found that low to moderate-intensity RT programs (~60-65% of 1-RM; 8-15RM; 45 MET) consisting of ~3 sets of 10-12 repetitions for ~8 exercises (3-4 upper and 4-5 lower body
exercises) performed ~3 days∙wk-1 for 14 weeks significantly reduced resting BP ~5-6 mmHg among
adults with hypertension. We observed even greater BP reductions following RT programs that
involved ≥8 versus <8 RT exercises per session, and when dynamic RT was performed ≥3 versus <3
days∙wk-1. Even so, important features of the RT intervention (i.e., RT intensity/load, rest interval
duration, etc.) were inconsistently reported so that the optimal FIT exercise prescription for dynamic
RT among adults with hypertension is not clear (Appendix 16).
We also identified patient characteristics that may benefit the most from dynamic RT as
stand-alone antihypertensive therapy. Namely, BP reductions were greater among samples who were
not taking antihypertensive medications (~4 mmHg) compared to those that were (~1 mmHg).
Although some studies have reported a synergistic effect between BP medication and the BP
reductions following RT [29, 107, 108], others have found no difference in the resultant BP
reductions between the two [21, 22, 30]. It is noteworthy to mention that only a small proportion of
our RT sample was currently taking BP-lowering medications (~17%); this may be a reflection that
approximately one-third of RT trials failed to disclose medication use, and the smaller number of
samples with hypertension (~11%; k=8) than prehypertension (~71%; k=50) and normal BP (~18%;
k=13) in our meta-analysis.
We found that dynamic RT elicited BP reductions that were comparable to or greater than
those achieved with aerobic exercise training among adults with hypertension, particularly for nonWhite samples (i.e., Asian, Hispanic/Latino and African American), who achieved BP reductions
approximately double the magnitude (~10-14 mmHg) associated with aerobic exercise training. To
the best of our knowledge only one meta-analysis [56] has investigated the potential impact of
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ethnicity/race on the BP response to exercise training. Whelton and colleagues [56] found that
aerobic exercise training reduced resting BP to greater levels among Asian (6/7 mmHg) and Black
(11/3 mmHg) compared to White samples (3/3 mmHg) (p<0.05). We observed a similar trend where
greater BP reductions occurred among Hispanic/Latino (~13/10 mmHg; k=14) and Asian (~11/10
mmHg; k=12) compared to White samples (~9/10 mmHg; k=40), differences that achieved statistical
significance only when examined collectively as non-White versus White samples. These findings
are important because certain Hispanic/Latino and Asian populations experience a disproportionate
burden of obesity and hypertension-related diseases [1, 109, 110], and these health disparities are
further exacerbated by lower cardiorespiratory fitness levels and more sedentary lifestyles [1, 111113] compared to Whites. Therefore, Hispanic/Latino, Asian and other racial/ethnic minority
populations are less likely to engage in exercise as antihypertensive therapy despite the fact our
findings showed they are the patients who may benefit the most. Our findings are promising in that
they provide another viable therapeutic exercise option that can be performed in addition to aerobic
exercise as stand-alone antihypertensive lifestyle therapy.
Even though we examined several sources for potential biases, of which some addressed the
validity of the BP assessment methods used, it important to stress the poor reporting of these
variables in this literature. Several reviews [4-6, 114] have commented on how the level of reporting
and quality of BP assessment procedures may contribute to the discrepancies observed across studies
in the magnitude of the BP reductions following exercise (i.e., unaccounted sources of
heterogeneity). Yet, ~31% of RT interventions failed to disclose any BP assessment procedures,
while ~20-30% of RT trials failed to report specific details that included: the type of BP monitor or
assessment tool (82% did), the body position during the BP measurement (69% did), and the timing
of BP measurements at baseline (52% did) and post-intervention (20% did). At this time, it is unclear
how the poor reporting and variability in these parameters influenced our results.
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In summary, our high quality methodological meta-analysis, which adhered to contemporary
standards, revealed that dynamic RT is as effective if not more so than aerobic exercise as
antihypertensive therapy among those with hypertension, notably non-White samples. These results
indicate that the present exercise recommendations for hypertension should be revisited to include
dynamic RT (in addition to aerobic exercise) as stand-alone antihypertensive lifestyle therapy.
Despite these promising findings, this body of literature is of fair to moderate quality with other
limitations noted within. Additional RCTs are needed to investigate RT as a viable stand-alone
therapeutic exercise option among more ethnically/racially diverse samples with hypertension.
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Table 1. Summary of the baseline characteristic for dynamic resistance training and
non-exercise control groups.
Dynamic RT
Control
Characteristic
k
(n=1, 304)
k
(n=1, 070)
68
49.3 (39.5, 59.0)
Women (%)
48.7 (39.1, 58.3)
69
67
47.2 ± 19.1
Age (years)
47.2 ± 19.0
68
48
BP Medication (% using)
14.1 (5.6, 22.5)
12.3 (4.5, 20.0)
48
Race/Ethnicity, % (n)
White
56.3 (774)
56.3 (628)
40
40
Asian
23.9 (263)
23.9 (258)
17
17
Hispanic/Latino/Caribbean
18.3 (254)
18.3 (251)
13
13
African American/Black
1.4 (13)
1.4 (15)
1
1
53
Sedentary (%)
92.6 (85.4, 99.8)
92.4 (85.1, 99.8)
54
Body Composition
59
Body weight (kg)
75.0 ± 11.7
74.1 ± 12.0
61
-2
58
Body Mass Index (kg∙m )
26.8 ± 3.4
26.6 ± 3.7
60
17
Waist circumference (cm)
96.9 ± 9.3
96.1 ± 10.0
17
36
Body Fat (%)
29.7 ± 6.9
29.3 ± 7.9
36
11
Fat Mass (kg)
26.4 ± 6.8
26.7 ± 7.2
11
20
Lean Mass (kg)
50.9
±
11.2
49.4 ± 11.1
20
Resting Hemodynamics
126.7 ± 10.3
70
126.3 ± 9.4
Systolic BP (mmHg)
71
76.8
±
8.7
70
76.5 ± 8.6
Diastolic BP (mmHg)
71
93.2 ± 8.0
70
93.2 ± 8.2
MAP (mmHg)
71
49.4 ± 8.3
70
49.8 ± 6.8
Pulse Pressure (mmHg)
71
70.1
±
6.9
40
69.1 ± 7.3
Heart rate (beats∙min-1)
41
Strength and Fitness Measures
10
Upper body strength (kg) *
44.5 ± 31.3
43.4 ± 36.5
18
16
Lower body strength (kg) †
92.3 ± 58.8
97.3 ± 69.7
24
36
Cardiorespiratory Fitness ‡
37
Oxygen Uptake (ml∙kg∙min-1)
24
28.6 ± 9.9
23
29.7 ± 9.4
Note. Based on 71 observations (k). Summary statistics are presented as Mean ± Standard
Deviation or as Mean (Lower, Upper 95% Confidence Interval). Abbr. BP=Blood pressure.
MAP=Mean arterial pressure. RT=Resistance training. * Upper body strength was assessed in
25 RT and 14 Control groups; k=18 and k=10 quantified pre-intervention strength in kilograms.
† Lower body strength was assessed in 33 RT and 24 Control groups; k=24 and k=16
quantified pre-intervention strength in kilograms. ‡ Fitness was assessed in 37 RT and 36
Control groups; k=24 and k=23 measured pre-intervention fitness as peak or maximal oxygen
uptake.
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Chapter 4
Discussion
The present dissertation includes two meta-analyses that aimed to determine the influence of
modality on the antihypertensive effects of exercise and to identify what combinations of patient
clinical characteristics and exercise intervention features elicited optimal therapeutic BP benefit. This
chapter provides a summary of our most relevant findings and serves as the concluding statement on
the antihypertensive effects of AET and dynamic RT. First, we will overview our major findings as
they relate to our specific aims and hypotheses. This will be followed by a discussion on the
implications of our findings on the current exercise recommendations for adults with hypertension.
Finally, we will discuss the remaining gaps in the existing literature and present potential directions
for future research.
4.1 Specific Aims and Hypotheses
The results from these two meta-analyses support our initial specific aims and hypotheses for
outlined in Chapter 1. Below find a reiteration of our major findings for AET and dynamic RT in the
context of our specific aims and hypotheses.
Specific Aim 1: To meta-analyze the existing AET literature with high quality methods to
determine the effectiveness of AET as an antihypertensive therapy and identify what patient clinical
and AET FIT characteristics elicit optimal antihypertensive BP benefit.
Hypothesis 1: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP
medication use, etc.) and AET FIT characteristics will moderate the antihypertensive effects of AET.
We observed that AET on average reduced BP by ~3-4 mmHg compared to control. Of note,
we found that BP reductions occurred in dose response fashion such that greater BP reductions were
observed among samples with hypertension (~7/6 mmHg) than prehypertension (~5/4 mmHg), and
normal BP (~3/1 mmHg). Furthermore, even larger BP reductions were observed among samples
with hypertension that achieved large gains in physical fitness and performed high volumes of AET,
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an effect that was more pronounced among non-White (~12 mmHg) than White (~6-7 mmHg)
samples. Our results confirm the effectiveness of AET as antihypertensive lifestyle therapy for adults
with hypertension, notably among African American (i.e., non- Hispanic Blacks), Asian, and
Hispanic/Latino samples, who achieved BP reductions that nearly doubled the magnitude previously
reported for AET.
Specific Aim 2: To meta-analyze the existing dynamic RT literature with high quality methods
to determine the effectiveness of RT as stand-alone antihypertensive therapy and identify important
moderators (i.e., patient clinical and RT FIT characteristics) of the BP response to provide insight
into the optimal dose of RT to lower BP among adults with hypertension.
Hypothesis 2: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP
medication use, etc.) and RT FIT characteristics will moderate the antihypertensive effects of
dynamic RT and provide insight into the optimal dose of RT as stand-alone antihypertensive therapy
for adults with hypertension.
We observed that dynamic RT on average reduced BP by ~2-3 mmHg compared to control.
However, we found that BP reductions occurred in dose response fashion such that greater BP
reductions were observed among samples with hypertension (~6/5 mmHg) than prehypertension
(~3/3 mmHg), and normal BP (~0/1 mmHg). Furthermore, even larger BP reductions were observed
among samples with hypertension following RT that involved ≥8 RT exercises per session and was
performed 3 or more days·week-1, an effect that was more pronounced among non-White (~10-14
mmHg) than White (~9-10 mmHg) samples. Our results revealed that dynamic RT is as effective if
not more so than AET as antihypertensive therapy among those with hypertension, notably
Hispanic/Latino and Asian samples. These results indicate that the present exercise recommendations
for hypertension should be revisited to include dynamic RT (in addition to aerobic exercise) as standalone antihypertensive lifestyle therapy. In addition, high quality RCTs should be designed to further
substantiate our findings.
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4.2 Additional Findings
In addition to our major findings detailed above, we also observed several interesting patterns
related to the overall methodological study quality of the included trials, and sources of potential bias
that may have contributed more substantially to the “fair to moderate” quality of the AET and
dynamic RT literature. Overall, we found that primary-level AET and RT interventions included in
our meta-analyses achieved similar methodological study quality (~65% and 63%), and for both
modalities, there was considerable range in percentage of quality items that were fully satisfied, with
overall methodological quality ranging from low (40%) to high (86%) [1, 2]. Surprisingly, only two
AET interventions satisfied ≥80% of study quality items (83.6%±2.8%), which suggests ‘higher
quality’, whereas seven RT trials achieved ≥80% (83.3%±1.3%).
Overall, AET and RT interventions yielded similar patterns regarding methodological deficits
and potential risk of biases gauged as the percentage of items fully satisfied using an augmented
version of the Downs and Black Checklist. This instrument [3] is well validated in the health
promotion literature and has been shown to be valid and reliable in assessing RCTs and non-RCTs.
The Downs and Black Checklist [3] addresses five subscales of methodological quality, making it
one of the most comprehensive extant instruments to evaluate study quality [4]. The methodological
subscales address potential risk for bias as it relates to: (1) reporting (i.e., how well were the
intervention details and other important information reported so that readers could make an unbiased
assessment of the study findings); (2) external validity (i.e., addresses the extent to which the study
ﬁndings can be generalized to the population from which the study subjects were derived); (3)
internal validity-bias (i.e., addresses the biases associated with the measurement of the intervention
and the study outcomes); (4) internal validity-confounding (i.e., addresses the bias in the selection of
study subjects); and (5) power (i.e., assesses whether the negative ﬁndings from a study could be due
to chance, i.e., inadequately powered sample to detect study findings) [3]. AET and RT interventions
were least likely to satisfy the methodological subscales that addressed external validity (AET:
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49.6%±40.7; RT: 46.5%±42.3) and power (AET: 1.7%±11.7%; RT: 9.2%±24.4%). None of the
individual methodology quality subscales emerged as significant moderators of the BP response to
AET or dynamic RT. These findings highlight the significant limitations of the existing exercise and
hypertension literature, namely that primary-level interventions lack the ability to generalize their
findings to the population from which the study subjects were derived (i.e., poor external validity)
and trials were not designed based on the sample size needed to detect exercise-related BP changes
[5, 6]. As a result, research syntheses, i.e., meta-analyses, of these exercise interventions may be
subject to the same limitations. Furthermore, exercise interventions that fail to fully satisfy these
particular subscales add to the uncertainty and discrepancies observed across trials in the magnitude
of BP reductions following exercise. It is unclear whether exercise interventions fail to observe
significant BP reductions as a result of the Ex Rx employed the clinical population enrolled, or a
small sample that was inadequately powered. Indeed, despite our meta-analyses constituting some of
the largest samples to date [7], only 26% (k=27) of AET and 11% (k=8) of RT interventions involved
adults with hypertension and sample sizes on average were small (n=18-20 participants).
Furthermore, we found that nearly 12% (k=10) of AET and 14% (k=9) of the RT trials
incorporated a “placebo” or “active control” group instead of a, non-exercise or “wait-list” condition.
Although this study design feature did not emerge as a significant moderator in either meta-analysis,
it may have underestimated the antihypertensive effects of AET and dynamic RT. BP reductions
were significantly smaller when compared to the placebo or active control groups (AET: -3.4/+0.8
mmHg; RT: +0.1/-0.3 mmHg) than all control groups (AET: -3.5/-2.7 mmHg; RT: -3.0/-2.1 mmHg).
4.3 Implications for the Exercise Prescription Recommendations for Hypertension
Based on the synthesis of the AET and dynamic RT literature presented in each metaanalysis, the following FITT-VP Ex Rx guidelines are suggested as a possible modification or
expansion of the current exercise recommendations for hypertension:
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Frequency: AET reduced resting BP to the greatest extent among adults with hypertension (~6-7
mmHg). These reductions occurred with AET performed ~3-4 days·week-1. Accordingly, AET
should be performed on at least 3 days·week-1, preferably most days of the week, to achieve
optimal BP benefits. These recommendations are consistent with the current ACSM
recommendations for hypertension [8] and other professional organizations/committees [6].
Frequency: Dynamic RT reduced resting BP to the greatest extent among adults with hypertension
(~5-6 mmHg). These reductions occurred with RT regimes that were performed ~3 days·week-1.
However, we observed greater BP reductions when RT was performed on 3 or more days·week -1.
Accordingly, dynamic RT should be performed 3-4 days·week-1 (in addition to aerobic exercise)
as stand-alone antihypertensive lifestyle therapy. These recommendations are a departure from the
current ACSM recommendations for hypertension [8] and other professional
organizations/committees [8-12] that who endorse dynamic RT on ≥2 days∙week-1 as adjuvant
antihypertensive lifestyle therapy to AET.
Intensity: AET performed at moderate-to-vigorous intensity (62.6%±10.6% VO2peak [range: 40-83%
VO2peak]; 5.9±1.7 MET [range: 3-12 MET]) elicited BP reductions of ~6-7 mmHg among adults
with hypertension. Nonetheless, high exercise volumes achieved with higher intensity (~8 MET)
were more efficacious as antihypertensive among adults with hypertension (~9-12 mmHg). Our
findings contribute to the growing body of literature that supports greater BP reductions can be
achieved with greater levels of exertion, if the patient is willing and able to tolerate higher levels
of exertion [13-15]. These recommendations align with ACSM [8] and others [6], and are
consistent with the Lifestyle Work Group [10] and American Heart Association [9], who also
endorse vigorous or high-intensity exercise.
Intensity: Dynamic RT performed at low-to-moderate intensity (64.7%±13.0% of 1-RM [range: 4080% of 1-RM]; range in 1-RM values: 8-15RM; 4.7±1.8 MET [range: 3-8 MET]) was sufficient to
elicit BP reductions of ~5-6 mmHg among adults with hypertension. However, we observed RT
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programs that involved ≥8 versus <8 RT exercises per session were more efficacious as standalone antihypertensive among adults with hypertension (~9-14 mmHg). These RT programs
consisted of a greater number of upper (6 versus 3 exercises·session-1) and lower body (5 versus 4
exercises·session-1) (ps<0.001), a higher number of repetitions performed per set (13 versus 10
repetitions·set-1, p=0.038), and shorter rest intervals between sets and exercises (30-60 versus 90120 seconds, p=0.021) than RT programs involving <8 exercises per session. Nonetheless, many
important features of the RT intervention were inconsistently reported, missing, or ranged
considerably across trials so that the optimal FIT for dynamic RT as stand-alone antihypertensive
therapy remains unclear [16, 17]. These recommendations are consistent with the current RT
recommendations for healthy adults [18], and adults those with hypertension put forth by the
ACSM [8] and other professional organizations/committees [8-12].
Time: AET performed for ~40 min·session-1 was sufficient in lowering resting BP ~6-7 mmHg
among adults with hypertension. Based on the recommended AET Frequency, adults with
hypertension should accumulate ~120-200 min·week-1, which is consistent with the current
exercise recommendations of ≥150 min·week-1 [6, 8].
Time: Dynamic RT programs that consisted of ~3 sets of 10-12 repetitions for ~8 exercises (3-4
upper and 4-5 lower body exercises) significantly reduced resting BP ~5-6 mmHg among adults
with hypertension. Overall, the average RT duration was not widely reported (~52% did; k=37),
but of those that did, RT sessions lasted ~40-50 min∙session-1. Based on the recommended RT
Frequency, adults with hypertension should accumulate ~120-200 min·week-1, which aligns with
the exercise recommendations for hypertension [8] and for RT for healthy adults [18].
Type: AET should emphasize dynamic, aerobic activities such as walking, jogging, swimming,
running, and cycling [8]. Dynamic RT should target the major muscle groups of the upper and
lower body and can be performed using machine or free weights using a conventional or circuitstyle training approach [8, 18].
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Volume: AET volume on average totaled ~850 MET∙min∙week-1 and elicited BP reductions of 6-7
mmHg among adults with hypertension. However, AET consisting of high volumes of exercise
(~1200 MET∙min∙week-1) were most efficacious in reducing BP among adults with hypertension
(~9-12 mmHg), notably among non-White samples (~12 mmHg). It is noteworthy to mention that
in our meta-analysis, high AET volume was achieved with more rigorous intensity AET (~8
MET) performed on 3-5 days·week-1 for 30-40 min·session-1, and not through combinations of
lower intensity, higher frequency (>5 days·week-1) and longer duration (>40 min·session-1) AET.
This volume of exercise is within the range ACSM recommends for healthy adults (500-≥1000
MET∙min∙week-1) [19]. Nonetheless, our results support that higher volumes of exercise appear to
maximize the antihypertensive benefit of AET for adults with hypertension. Dynamic RT that
consisted of ~3 sets of 10-12 repetitions for ~8 exercises (~45 min∙session-1), performed at low-tomoderate intensity on 3-4 days∙week-1 totaled on average ~575 MET∙min∙week-1 (calculated as
Frequency × Intensity [MET] × Time). This volume of RT elicited BP reductions of 5-6 mmHg
among adults with hypertension and is consistent with ACSM’s recommendations for healthy
adults (500-≥1000 MET∙min∙week-1) [19] .
Progression: Overall, the FITT-VP principle of the Ex Rx for healthy adults is applicable for those
with hypertension. Modifications may need to be made to the Ex R x under circumstances such as;
a) improvement or worsening of BP control; b) development of co-morbid conditions; c) changes
to BP or other medication use; and/or d) injury or physical disability. In general, the ACSM
special considerations for AET and dynamic RT are still applicable and should be followed as
necessary [14, 19]. The progression of AET and dynamic RT should be gradual, and tailored to
individual patient’s ability and tolerance [14, 19].
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4.4 Additions to the Existing Literature
4.4.1 Aerobic Exercise Training
Our meta-analysis adds new and important contributions to the scarce body of literature that
has identified patient characteristics ( i.e., resting BP [20-23], race/ethnicity [24], age [25], and
sex/gender [23]) and aspects of the FIT [25, 26] that modulate BP reductions following AET. We
confirmed that AET is effective antihypertensive therapy for adults with hypertension, and that AET
elicits BP reductions in a dose-response fashion such that the greatest BP reductions were observed
among samples with hypertension (~7/6 mmHg) followed by prehypertension (~5/4 mmHg), and
normal BP (~3/1 mmHg) [20-23]. In addition, we found AET programs that elicited large fitness
gains (>25% to ~50%) and promoted high volumes of exercise (~1200 MET∙min∙week -1) maximized
the antihypertensive benefits of AET among adults with hypertension (~9 mmHg), an effect that was
more pronounced among non-White (~12 mmHg) than White (~6-7 mmHg) samples.
Our most noteworthy and clinically relevant findings were that: (1) moderate-vigorous
intensity AET reduced BP in a dose-response fashion, (2) large gains in physical fitness and high
volumes of exercise elicited the greatest BP reductions among adults with hypertension, which are
larger than previously reported, and (3) the antihypertensive benefits of AET were greatest among
non-White samples, notably African American (i.e., non- Hispanic Blacks), Asian, and
Hispanic/Latino populations, with hypertension that achieved BP reductions approximately double
the magnitude (~12 mmHg) previously reported for AET.
4.4.2 Dynamic Resistance Training
Our meta-analysis adds novel information to the existing literature, namely that we are the
first to document that RT reduces BP in dose-response fashion such that the greatest BP reductions
occurred among samples with hypertension (~6/5 mmHg), followed by prehypertension (~3/3
mmHg), whereas those observed among samples with normal BP were negligible (~0/1 mmHg).
Second, we are the first to identify features of the RT FIT that influenced the BP response to dynamic
90

RT. In agreement with the current exercise recommendations for hypertension, we found that low-tomoderate-intensity RT programs (~60% of 1-RM) consisting of ~3 sets of 10-12 repetitions for ~8
exercises (3-4 upper and 4-5 lower body exercises) performed on ~3 days∙wk-1 significantly reduced
resting BP ~5-6 mmHg among adults with hypertension. However, we observed the greatest BP
reductions among adults with hypertension following RT programs that involved ≥8 versus <8 RT
exercises per session, and when dynamic RT was performed ≥3 versus <3 days∙wk -1, (~9-14 mmHg),
an effect that was more pronounced among non-White samples (i.e., Hispanic/Latino and Asian). Our
most noteworthy and clinically relevant findings were that: (1) dynamic RT elicited BP reductions
that were comparable to or greater than those achieved with AET among adults with hypertension,
particularly among non-White samples, and (2) RT reduced BP in dose-response fashion, findings
that align with those reported for AET [6-8], but not with other meta-analyses examining the BP
response to RT. Our findings suggest that dynamic RT prescribed with the FIT recommendations
above may be recommended as stand-alone antihypertensive therapy among adults with hypertension
similar to the AET recommendations, however, new RCTs should be conducted to confirm this
proposition.
4.4.3 Exercise Training Literature
Aerobic exercise training (AET) is universally recommended as first line antihypertensive
lifestyle therapy due to the strong level of evidence supporting it lowers blood pressure (BP) 5-7
mmHg among most adults with hypertension [27]. Dynamic RT is recommended as adjuvant
antihypertensive lifestyle therapy to aerobic exercise training because there is a weaker body of
evidence indicating it lowers BP to lesser half that of AET among adults with hypertension (~2-3
mmHg) [6, 26, 28-32]. Therefore, the American College of Sports Medicine [8] and other
professional organizations and committees [9-12, 33] recommend 30-60 min∙day-1 of moderate
intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days of the week
supplemented by dynamic RT on ≥2 days∙wk-1 [8-12] as first-line antihypertensive therapy for the
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prevention, treatment, and control of hypertension. Yet, a more critical review of this literature
revealed considerable variability in the magnitude of the BP reductions from these recommendations
for both AET (i.e., 1-9 mmHg) [6] and dynamic RT (i.e., 0-6 mmHg) [8, 28, 30, 32]. Reasons for
inter- and intra-individual variability are not clear not clear [6, 9] but may be attributable to
differences in baseline sample clinical and exercise intervention characteristics (i.e., the FITT) of the
Ex Rx. Nonetheless, few meta-analyses have documented significant moderation patterns pertaining
to these characteristics [6, 7].
Our two meta-analyses addressed several of the research gaps noted above, notably, the fact
we identified combinations of patient clinical and FIT characteristics that optimized the
antihypertensive BP benefits following AET and dynamic RT among adults with hypertension. Some
of our findings contradict earlier statements made by the ACSM in their evidence-based position on
exercise and hypertension [8]. In particular, our findings related to race/ethnicity. In contrast to the
Category B level of evidence rating (i.e., fewer RCTs trials with inconsistent ﬁndings) and their
conclusion that “race/ethnicity does not modulate the BP response to exercise training”, we found
that greater BP reductions occurred among non-White (i.e., African American, Hispanic/Latino, and
Asian) than White samples following AET and RT. Collectively, these findings are important
because racial/ethnic groups often experience a disproportionate burden of hypertension and CVD
[34]. These health disparities are further exacerbated by lower cardiorespiratory fitness and more
sedentary lifestyles [34-37] compared to Whites. Thus, racial/ethnic minority populations are less
likely to engage in regular exercise as antihypertensive lifestyle therapy, despite the fact our findings
showed they are the patients who may benefit the most. Our findings highlight the critical need for a
more individualized, possibly, race/ethnicity-specific approach to the Ex Rx for hypertension in order
to maximize the effectiveness of exercise as antihypertensive therapy.
Second, our meta-analyses gauged the individual study quality for each included trial using
an augmented version of the Downs and Black Checklist [1, 2]. In addition, we quantitatively
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incorporated methodological study quality and quality-related features of the exercise interventions
(i.e., whether trials had BP-focused outcomes) to determine whether study quality independently [7,
38] or interactively [39] modulated the BP response to exercise training. We, along with prior metaanalyses [6, 7], have found the exercise and hypertension literature to be of ‘fair to moderate’
methodological quality [1, 2]. In the absence of a higher quality literature, there is the potential risk
of bias or other threats to the validity of our findings. For this reason, we explored potential sources
of bias related to the five quality subscales of the Downs and Black checklist, whether trials had BPfocused outcomes, and whether the publication year, type of trial (i.e., RCT versus non-RCT), or
number of funding sources influenced our results. We then statistically examined whether these
potential sources of biases modulated the BP response to AET and dynamic RT, and even when these
features were non-significant in bivariate meta-regression models, we incorporated them to control
for confounding or suppression effects that could arise from lower-quality trials [7, 39].
We found that higher study quality was associated with trials that: were published more
recently (AET: r=0.15, p=0.03; RT: r=0.45, p<0.001), were RCTs (versus non-RCTs) (AET:
r=0.36, p<0.001; RT: r=0.23, p=0.052), were adequately powered to detect BP outcomes (Downs
and Black Checklist Item 28) (AET: r=0.26, p=0.09; RT: r=0.41, p<0.001), and followed standard
protocols or established guidelines when measuring BP (i.e., American Heart Association Council on
High BP Research Part 1: Recommendations for BP measurement in Humans [40]) (RT: r=0.24,
p=0.045). Not surprisingly, trials that used standard protocols/established guidelines when assessing
BP were more likely to have BP-focused outcomes (AET: r=0.22, p=0.002) and used more reliable
and accurate BP assessment methods (Downs and Black Checklist Item 21) (r=0.19, p=0.006).
Interestingly, trials that were adequately powered also had greater amounts of funding support (AET:
r=0.68, p<0.001; RT: r=0.26, p=0.029). By examining the potential risk of bias from several sources
and incorporating them into our multiple moderator models, we can be more confident in our study
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results despite the number of methodological deficits and inconsistencies we have documented in this
literature.
4.5 Limitations
Despite our novel and important contributions, we identified other noteworthy gaps in the
extant literature. Other than Whelton and colleagues [24], no previous meta-analysis until ours has
documented race/ethnicity-dependent BP reductions following exercise training. Furthermore,
Whelton et al. [24] only identified race/ethnicity as a moderator of the BP response to AET, whereas
we found this moderation pattern persisted across modalities for both AET and RT. Unfortunately,
included trials rarely disclosed the race/ethnicity of their participants; only 18% of AET [27-41] and
14% of RT [22, 23, 42-48] trials reported this detail. Therefore, we employed the same strategy used
by Whelton et al. [24] to estimate race/ethnicity when it was missing. It is well documented that
certain racial/ethnic minority groups experience disproportionate health outcomes. Furthermore,
there is a growing body of research that has documented the different physiological responses
between ‘White’ and ‘non-White’ populations to the same exercise stimuli [41, 42], although the
mechanisms to explain these differences have yet to be fully elucidated. In order to meaningfully
contribute to this growing literature, a more comprehensive approach must be implemented for data
collection at the primary-level to ensure that these important patient clinical characteristics are
adequately reported.
Although we identified FIT characteristics that moderated the BP response to AET and
dynamic RT, we found that many important FIT characteristics and features of the exercise
intervention were assessed using a variety of methods (i.e., lack of standardization in
cardiorespiratory fitness and 1-RM testing procedures), and in many cases it was inconsistently
reported or missing completely. Given that training adaptations are specific to the stimulus applied
(i.e., principle of specificity), it is troubling that the majority of AET and RT trials failed to
adequately report important features of the Ex R x or properly assess training-induced changes in
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physical function, fitness, and strength. Inconsistent reporting of these intervention characteristics not
only precludes exercise professionals from identifying the optimal AET and RT Ex Rx FIT for adults
with hypertension, but limits our ability to gauge how well participants tolerated the Ex Rx (i.e.,
exercise adherence), and ultimately, its effectiveness as antihypertensive therapy.
Even though we examined several sources for potential biases, of which some addressed the
validity of the BP assessment methods used, it important to reinforce the poor reporting of these
variables in both the AET and RT literature. Several reviews [5-8] have commented on how the level
of reporting and quality of BP assessment procedures may contribute to the discrepancies observed
across studies in the magnitude of the BP reductions following exercise (i.e., unaccounted sources of
heterogeneity). Yet, 38% of AET and 31% of RT interventions failed to disclose any BP assessment
procedures, while ~20-30% of AET and RT trials failed to report specific details that included: the
type of BP monitor or assessment tool (75-80% did), the body position during the BP measurement
(69-72% did), and the timing of BP measurements at baseline (52-60% did) and post-intervention
(17-20% did). At this time, it is unclear how the poor reporting and variability in these parameters
influenced our results.
Finally, many of the limitations noted above are exacerbated by the use of aggregated data
(i.e., aggregate-level meta-analysis). Individual-participant data (IPD) meta-analysis is the
(emerging) gold standard in meta-analytic practice [43, 44], although it is rarely used in the exercise
and health promotion literature. IPD meta-analyses are superior to those performed with aggregateddata because it avoids such issues as restriction in range of moderators (e.g. mean sample versus
individual values that better capture the variability in training responses among samples) and
ecological fallacy (e.g. assuming that all members of the exercise group benefit equally) [43, 45, 46].
On the other hand, IPD meta-analysis presents with a unique set of challenges, namely that it requires
a greater time-commitment to obtain original, raw participant data from all relevant trials on specific
topic [47, 48]. Furthermore, IPD approaches depend on collaborative efforts and the willingness of
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researchers to share their data. If participant data is not available for all relevant trials, it is possible
that the results will not be representative of the existing literature and lack generalizability to the
population intended for treatment. Despite improved and likely greater precision in the analytic
results from IPD meta-analyses, it is possible that aggregate-level meta-analyses are more
appropriate to answer questions regarding the role of exercise training for the prevention, treatment
and management of hypertension (i.e., Simpson’s paradox [49, 50]). The decision to use aggregateddata versus IPD should be based on the most appropriate approach to answer the research question
based on the available data with important consideration given to the strengths and weaknesses of
their inherent assumptions [44, 45]. These steps, in addition to improved reporting transparency and
adherence to contemporary methodological standards, should reduce the likelihood of Simpson’s
Paradox [49, 50], that different trends will result from the application of different statistical analyses
and partitioning of data.
4.6 Strengths
Our meta-analyses had several strengths. The trial identification and selection process was
comprehensive, and without restrictive inclusionary criteria that has been used in previously
published meta-analyses. We strove to identify all potentially relevant reports from several electronic
databases searched from their inception until our pre-specified end search date; we sought to locate
reports in all languages regardless of publication status (i.e., our search permitted grey and
unpublished literature), which yielded two of the largest meta-analyses conducted to date (86 AET
trials,105 interventions; 64 RT trials, 71 interventions) [7]. We examined a priori, theoreticallydriven moderator analyses using more sophisticated [51, 52] and complex meta-analytic techniques
[53], that until now have not been used to examine the antihypertensive effects of exercise.
Consequently, our meta-analysis adhered to high-quality, contemporary methodological standards
[54, 55] and completely satisfied the criteria implied by the PRISMA Statement (Preferred Reporting
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Items for Systematic Review and Meta-Analyses) [54, 55] and the AMSTAR Scale (Assessment of
Multiple SysTemAtic Reviews) [38, 56].
4.7 Conclusions
In summary, our two high quality meta-analyses that adhered to contemporary
methodological standards revealed several important findings. First, we confirmed that AET is
effective antihypertensive therapy for adults with hypertension (~6-7 mmHg). We found for the first
time that high volume AET programs and large gains in physical fitness were associated with the
largest BP reductions (~9-10 mmHg), most notably for non-White samples (~12 mmHg). These
results indicate that the present exercise recommendations for hypertension should be revisited to
include individualized, race/ethnicity-specific exercise prescription recommendations for populations
who experience disproportionate adverse CVD outcomes, with the goal of improving physicianpatient interactions and adherence to exercise as lifestyle therapy.
Second, we demonstrated that BP reductions following RT occurred in dose response fashion
such that greater BP reductions occurred among samples with hypertension (~5-6 mmHg), which is
comparable to the magnitude reported with AET. Samples with hypertension that performed ≥8 RT
exercises per session, on 3-4 days∙wk-1 achieved the greatest BP reductions following RT (~9
mmHg), notably among non-White samples (~10-14 mmHg). Our results indicate that the present
exercise recommendations for hypertension should be revisited to include dynamic RT (in addition to
AET) as stand-alone antihypertensive lifestyle therapy.
Our findings suggest the following FITT-VP Ex Rx for the use of AET and dynamic RT as
stand-alone antihypertensive therapy:
Frequency: AET: 3-≥4 days·week-1, preferably most days of the week and dynamic RT: 3-4
days·week-1
Intensity: AET: Moderate-to-vigorous intensity (40->60% VO2peak; 3->6 MET). Progression to
vigorous intensity AET may be warranted if the patient is willing and able to tolerate higher
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levels of exertion. Dynamic RT: low-to-moderate intensity (~40-70% of 1-RM; 8-15RM; 3-<6
MET)
Time: AET: ~40 min∙session-1 and dynamic RT: ~3 sets of 10-12 repetitions for ~8-12 upper and
lower body RT exercises lasting ~40 min∙session-1 to achieve a total amount of weekly exercise
~120-200 min·week-1
Type: AET: dynamic, aerobic activities such as walking, jogging, swimming, running, and cycling
and dynamic RT: should target the major and can be performed using machine or free weights
using a conventional or circuit-style training approach that target the major muscle groups of
the upper and lower body. Our meta-analysis examined the antihypertensive effects of isolated
AET and RT, therefore it is unclear s how AET and dynamic RT should be combined as standalone antihypertensive therapeutic exercise options. Further investigations are warranted to
determine the optimal AET and RT FIT, specifically focused on whether AET and RT should
be performed on the same (i.e., concurrently) or separate days (i.e., combined), and if
concurrent exercise is most efficacious, further clarification is needed on whether AET should
be performed before versus after or simultaneously (i.e., intermittent training) with RT.
Volume: Moderate to high volumes of AET (~850 MET∙min∙week-1) and moderate volumes of
dynamic RT (~575 MET∙min∙week-1) totaling ≥1200 MET∙min∙week-1
Progression: In general, the special considerations already established in the ACSM’s guidelines
for AET and dynamic RT still apply. The progression of AET and dynamic RT should be
gradual, and tailored to individual patient’s ability and tolerance.
Despite the promising and positive findings from our two meta-analyses, the AET and
dynamic RT body of literature is of fair to moderate quality with other limitations noted within.
Additional high-quality RCTs that have BP-focused outcomes are needed to investigate the
antihypertensive effects of AET and RT as stand-alone or combined therapeutic exercise options
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among more racially/ethnically diverse samples with hypertension. Future researchers should also
incorporate standard assessment methodology for key variables, such as cardiorespiratory fitness,
strength (1-RM), and manipulate the AET and RT FIT characteristics to further clarify the optimal
‘dose’ of exercise to lower BP among adults with hypertension.
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Appendix 1. Full search strategy used for electronic databases.
Note. Full electronic search strategies for five databases, PubMed, Scopus (including EMBASE),
Web of Science, SPORTDiscus, and CINAHL (Cumulative Index to Nursing and Allied Health
Literature), are listed below. For each of the databases searched no start date was applied, and each
database was searched from their inception or date of the earliest available publication.
PubMed (including MEDLINE). Hits = 8, 417
Vendor/Platform: National Library of Medicine. Coverage: Date of inception 1940’s – January 31, 2014
PubMed was searched with appropriate Medical Subject Headings (MeSH) incorporated into hedges.
Filters were set for Humans:
("mean arterial" OR "blood pressure"[mesh] OR "blood pressure" OR "blood pressures" OR "arterial
pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR
hypertensive OR antihypertensive OR hypotensive OR normotensive OR "systolic pressure" OR
"diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR
hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp
monitor" OR "bp monitors" OR "bp measurement")
AND ("exercise"[majr] OR exercise[ti] OR exercises[ti] OR exercising[ti] OR postexercise[ti] OR
running[mesh] OR running[ti] OR bicycling[mesh] OR bicycling OR bicycle* OR cycling[ti] OR
treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR
"strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training
duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic
training" OR "interval training" OR "combination training" OR "combined training" OR
plyometric* OR "HIIT" OR walking[mesh] OR walking[ti] OR swimming)
AND ("randomized controlled trial"[pt] OR "controlled clinical trial"[pt] OR "random allocation" [mh]
OR "clinical trial"[pt] OR "clinical trial"[tw] OR "latin square"[tw] OR random*[tw] OR "research
design" [mh:noexp] OR "comparative study"[publication type] OR "evaluation studies"[publication
type] OR "prospective studies" [mh] OR "cross-over studies" [mh] OR control[tw] OR
controlled[tw])
NOT ("DASH"[tiab] OR cancer OR neoplasms OR review[pt] OR fibromyalgia OR alzheimers OR
alzheimer OR pregnant OR pregnancy OR "obesity/drug therapy"[mesh] OR pharmacol*[ti] OR
drug[ti] OR pharmacist*[ti] OR "diet therapy"[mesh] OR "diet therapy"[subheading] OR
"nutritional intervention" OR "dietary intervention" OR "nutritional counseling" OR "dietary
counseling" OR caffeine OR "eating change" OR "activities of daily living" OR "dehydration" OR
"dehydrate" OR "dehydrated" OR "dietary salt" OR sodium OR epilepsy OR influenza OR flu OR
pneumonia OR septicemia OR arthritis OR hiv OR "Acquired Immunodeficiency Syndrome" OR
meningitis OR "substance abuse" OR alcoholism OR "drug abuse" OR "Cross-Sectional
Studies"[MeSH Terms] OR "Case Reports"[pt] OR Comment[pt] OR Editorial[pt] OR Letter[pt] OR
Review[pt] OR "case control"[ti] OR "case report"[ti] OR "case study"[ti] OR "case series"[ti] OR
"Case-Control Studies"[Mesh] OR "Follow-Up Studies"[Mesh] OR "observational study"[ti] OR
"prospective cohort"[ti] OR "cohort studies" [Mesh:NoExp] OR "cohort study"[ti] OR "Longitudinal
Studies" [Mesh:NoExp] OR "Follow-Up Studies"[mesh] OR "Retrospective Studies"[mesh] OR
"follow up study"[ti] OR rat[ti] OR rats[ti] OR mice[ti] OR mouse[ti] OR dog[ti] OR dogs[ti] OR
cats[ti] OR "epidemiology"[Subheading])
Scopus (including EMBASE). Hits = 9, 354
Vendor/platform: Elsevier SciVerse. Coverage: Date of inception 1960 – January 31, 2014
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Scopus was searched for the following terms in the “Article title, abstract, keywords.” Filters were set
for Document Type, excluding: Review, Letter, Note, Editorial.
Line 1 (in article, title, abstract, keywords): ({mean arterial} OR {blood pressure} OR {blood
pressures} OR {arterial pressure} OR {arterial pressures} OR hypertension OR hypotension OR
normotension OR hypertensive OR hypotensive OR normotensive OR {systolic pressure} OR
{diastolic pressure} OR {pulse pressure} OR {venous pressure} OR {pressure monitor} OR
hypotension OR {pre hypertension} OR {bp response} OR {bp decrease} OR {bp reduction} OR
{bp monitor} OR {bp monitors} OR {bp measurement})
AND Line 2 (in article, title, abstract, keywords): (bicycling OR bicycle* OR treadmill* OR
ergometer* OR {weight lifting} OR {weight training} OR {resistance training} OR {strength
training} OR {endurance training} OR {speed training} OR {circuit training} OR {training
duration} OR {training frequency} OR {training intensity} OR {aerobic endurance} OR {aerobic
training} OR {interval training} OR {combination training} OR {combined training} OR
plyometric* OR HIIT OR swimming)
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR
cycling OR walking)
AND Line 4 (in article, title, abstract, keywords): ({clinical trial} OR {latin square} OR random*
OR {comparative study} OR {evaluation study} OR {evaluative study} OR {prospective study} OR
{cross-over study} OR control OR controlled)
NOT Line 5 (in article, title, abstract, keywords): (DASH OR cancer OR neoplasms OR
fibromyalgia OR alzheimer* OR pregnant OR pregnancy OR {nutritional intervention} OR {diet
therapy} OR {dietary intervention} OR {nutritional counseling} OR {dietary counseling} OR
caffeine OR {eating change} OR {activities of daily living} OR dehydration OR dehydrate OR
dehydrated OR {dietary salt} OR sodium OR epilepsy OR influenza OR flu OR pneumonia OR
septicemia OR arthritis OR hiv OR {Acquired Immunodeficiency Syndrome} OR meningitis OR
{substance abuse} OR alcoholism OR {drug abuse})
OR Line 6 (in article title): (review OR pharmacol* OR drug OR pharmacist* OR {cross-sectional}
OR {case report} OR comment OR commentary OR editorial OR letter OR {case control} OR {case
study} OR {case series} OR {follow-up study} OR {observational study} OR {prospective cohort}
OR {cohort study} OR {longitudinal study} OR {retrospective study} OR rat OR rats OR mice OR
mouse OR dog OR dogs OR cats OR {epidemiology})
Web of Science (also known as Web of Knowledge). Hits = 3, 658
Vendor/platform: Thomson Reuters. Coverage: Earliest date available 1974 – January 31, 2014
Web of Science was searched using the following terms as “Topic” words. Filters were set for
Document Type, including only: Articles, Proceedings Papers. Due to database limitations, excluded
terms (i.e., “NOT” terms) were only searched in the article titles, and was performed using
RefWorks.
Line 1 (in topic): ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure"
OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR
hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure"
OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp
response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp
measurement")
AND Line 2 (in topic): (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR
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"weight training" OR "resistance training" OR "strength training" OR "endurance training" OR
"speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination
training" OR "combined training" OR plyometric* OR HIIT OR swimming)
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR
cycling OR walking)
AND Line 4 (in topic): ("clinical trial" OR "latin square" OR random* OR "comparative study" OR
"evaluation study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control
OR controlled)
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention"
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR
"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study"
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR
mouse OR dog OR dogs OR cats OR "epidemiology")
SPORTDiscus. Hits = 537
Vendor/platform: EbscoHost. Coverage: Date of inception 1975 – January 31, 2014
SportDiscus was searched for the following terms as “Topic” words. Filters were set for Publication
Type, including only: Journal Articles; Peer Reviewed; Academic Journals:
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial
pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive
OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous
pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp
decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement")
AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight
training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed
training" OR "circuit training" OR "training duration" OR "training frequency" OR "training
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination
training" OR "combined training" OR plyometric* OR HIIT OR swimming)
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR
cycling OR walking)
AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation
study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR
controlled)
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention"
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR
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"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study"
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR
mouse OR dog OR dogs OR cats OR "epidemiology")
CINAHL: Cumulative Index to Nursing and Allied Health Literature. Hits = 122
Vendor/Platform: EbscoHost. Coverage: Date of inception 1981 – January 31, 2014
CINAHL was searched with appropriate CINAHL subject headings incorporated into hedges, though
not shown below, medical headings were included for “blood pressure”, “exercise”, “running”, and
“weight lifting”. Filters were set for Research Article; Humans, All Adults. CINAHL hits excluded
MEDLINE records.
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial
pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive
OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous
pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp
decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement")
AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight
training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed
training" OR "circuit training" OR "training duration" OR "training frequency" OR "training
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination
training" OR "combined training" OR plyometric* OR HIIT OR swimming)
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR
cycling OR walking)
AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation
study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR
controlled)
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention"
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR
"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study"
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR
mouse OR dog OR dogs OR cats OR "epidemiology")
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Appendix 2. Reference list for the included aerobic exercise training trials (n=84). Aerobic
exercise training studies with >1 independent interventions (n=6) are bolded below (k=90
interventions).
[1] Albright CL, King AC, Barr Taylor C,
Haskell WL (1992) Effect of a six-month aerobic
exercise training program on cardiovascular
responsivity in healthy middle-aged adults. J
Psychosom Res 36:25-36

normotensive subjects 60 to 79 years of age. Am J
Cardiol 73:1124-1128
[10] Chaudhary S, Kang MK, Sandhu JS (2010) The
effects of aerobic versus resistance training on
cardiovascular fitness in obese sedentary females.
Asian Journal of Sports Medicine 1:177-184

[2] Arora E, Shenoy S, Sandhu JS (2009) Effects of
resistance training on metabolic profile of adults
with type 2 diabetes. Indian J Med Res 129:515-519 [11] Cononie CC, Graves JE, Pollock ML,
Phillips MI, Sumners C, Hagberg JM (1991)
[3] Bateman LA, Slentz CA, Willis LH, et al. (2011) Effect of exercise training on blood pressure in
Comparison of Aerobic Versus Resistance Exercise 70- to 79-yr-old men and women. Med Sci Sports
Training Effects on Metabolic Syndrome (from the Exerc 23:505-511
Studies of a Targeted Risk Reduction Intervention
Through Defined Exercise - STRRIDE-AT/RT). Am [12] Cooper AR, Moore LA, McKenna J, Riddoch
J Cardiol 108:838-844
CJ (2000) What is the magnitude of blood pressure
response to a programme of moderate intensity
[4] Beck DT, Martin JS, Casey DP, Braith RW
exercise? Randomised controlled trial among
(2013) Exercise training improves endothelial
sedentary adults with unmedicated hypertension. Br
function in resistance arteries of young
J Gen Pract 50:958-962
prehypertensives. J Hum Hypertens
[13] Dalleck LC, Allen BA, Hanson BA, Borresen
[5] Bell GJ, Harber V, Murray T, Courneya KS,
EC, Erickson ME, De Lap SL (2009) Dose-response
Rodgers W (2010) A comparison of fitness training relationship between moderate-intensity exercise
to a pedometer-based walking program matched for duration and coronary heart disease risk factors in
postmenopausal women. J Womens Health
total energy cost. J Phys Act Health 7:203-213
(Larchmt) 18:105-113
[6] Bernardi L, Radaelli A, Passino C, et al. (2007)
Effects of physical training on cardiovascular control [14] Davies B, Daggett A (1977) Responses of adult
after heart transplantation. Int J Cardiol 118:356-362 women to programmed exercise. Br J Sports Med
11:122-126
[7] Blumenthal JA, Siegel WC, Appelbaum M
(1991) Failure of exercise to reduce blood pressure [15] Edwards DG, Schofield RS, Magyari PM,
in patients with mild hypertension. Results of a
Nichols WW, Braith RW (2004) Effect of exercise
randomized controlled trial. JAMA 266:2098-2104 training on central aortic pressure wave reflection in
coronary artery disease. Am J Hypertens 17:540-543
[8] Bowman AJ, Clayton RH, Murray A, Reed JW,
Subhan MM, Ford GA (1997) Effects of aerobic
[16] Ferrier KE, Waddell TK, Gatzka CD, Cameron
exercise training and yoga on the baroreflex in
JD, Dart AM, Kingwell BA (2001) Aerobic exercise
healthy elderly persons. Eur J Clin Invest 27:443training does not modify large-artery compliance in
isolated systolic hypertension. Hypertension 38:222449
226
[9] Braith RW, Pollock ML, Lowenthal DT, Graves
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Appendix 3. Augmented version of the Downs and Black Checklist.
Individual Study Quality Items, Listed by Quality Subscale
1. Is the hypothesis/aim/objective of the study clearly described? †
2. Are the main outcomes to be measured clearly described in the Introduction or Methods section? †
3. Is BP a primary outcome? *
4. Are the characteristics of the study population included in the study clearly described? ‡
5. Are the interventions under study clearly described? ‡
6. Are the distributions of principal confounders in each intervention clearly described? †
7. Are the BP findings of the study clearly described? §
8. Are estimates of the random variability (e.g., SE, SD, CIs, etc.) for BP outcomes reported? §
9. Have all important adverse events/negative outcomes that may be a consequence of the intervention
been reported? If eligibility screening was reported, award partial score. ‡
10. Have the characteristics of study participants lost to follow up been described? †
11. Are actual values reported (e.g., 0.035 vs. <0.05) for BP outcomes except for values <0.001? §

Reporting

0

0

1
1

0
0

0 —
0 —

1

0

0 —

1

0

0 —

1

0

0 —

1

0

0 —

1
1

0
0

0 —
0 —

1

0

0 —

1

0

0 —

1

0

0 —

1

0

0

1

0

0 —

1

0

0 —

1

0

0

1

0

0 —

1

0

0 —

1

0

0 —

1/2 0

0 —

½

½

Items satisfied=___ (7 possible points)

22. Were study participants in the different intervention groups (trials and cohort studies) or were the
cases and controls (case-control studies) recruited from the same population? †
23. Were study participants in the different intervention groups (trials and cohort studies) or were the
cases and controls (case-control studies) recruited over the same period of time? †
24. Were study participants randomized to intervention groups? †
25. Was the randomized intervention assignment concealed from both study participants and
intervention staff until recruitment was complete and irrecoverable? †
26. Was there adequate adjustment in analyses for confounding from which the main findings were
drawn? †
27. Were losses of study participants to follow-up taken into account? †

Internal Validity – Confounding

1

Items satisfied=___ (3 possible points)

15. Were subjects “blinded” to their assigned intervention until recruitment and baseline/pre-training
measurements were completed and final? (i.e., subjects were unaware of the intervention they had
received until these processes were complete). §
16. Was an attempt made to blind those measuring BP outcomes of the intervention? §
17. If any of the results of the study were based on “data dredging”, was this made clear? †
18. In trials and cohort studies, do analyses adjust for different follow-up lengths for participants, or is
the time period between the intervention and outcome the same for cases and controls? †
19. Were the statistical tests used to assess the main outcomes appropriate? †
20. Was compliance with the intervention reliable based on reported exercise adherence, level of
supervision, or use of monitoring devices? §
21. Were the BP measures accurate? (i.e., were measures of resting BP and/ or ambulatory BP valid
and reliable based on the tool(s) and procedures?) §

Internal Validity – Bias

N U/D P
0 0 —
0 0 —
0 0 ½
0 0 ½
0 0 ½
0 0 ½
0 0 —
0 0 —

Items satisfied=___ (11 possible points)

12. Were study subjects asked to participate representative of the population they were recruited? †
13. Were study subjects who agreed to participate representative of the population they were
recruited? †
14. Were the staff, places, and facilities where the study subjects received the intervention
representative of the intervention the majority of subjects receive? †

External Validity

Y
1
1
1
1
1
1
1
1

½

Items satisfied=___ (6 possible points)

28. Was a power analysis conducted to determine the sample size needed to detect a significant
difference(s) in effect size for the BP or other outcome measure(s)? §

Power
Items satisfied=___ (2 possible points)
Total Study Quality Score =______ of 29 possible points (sum of all subscale scores)
Note. BP=Blood pressure. N=No, not satisfied. P=Partially satisfied. U/D=Unable to determine. Y=Yes, fully
satisfied. *New item (not part of original checklist). † Original item. ‡ Clarified from original checklist. §
Modified from original checklist.
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Appendix 4. Methods used to calculate the standardized mean difference effect size (ES)
estimations (and their components), and the unstandardized or raw metric (i.e., mmHg) for
different study designs.
1. The standardized mean difference ES estimate for two independent groups (i.e., parallel study design;
between-group ES) with a repeated-measures design (i.e., post- versus pre-intervention): Becker’s d
[1-3]:

,
Note. c(N−2)=Correction factor for small sample size bias and baseline differences, where
N=nEpost + nCpost (i.e., the total number of participants in the exercise and control groups postintervention). 𝑌̅Post; Pre=Mean blood pressure for the sample taken at post- and pre-intervention.
E=Exercise group. C=Non-exercise control group. Spre=Standard deviation of the pre-intervention blood
pressure for the exercise and control group.

2. The standardized mean difference ES estimate for a one-group (i.e., cross-over study design; withingroup ES) repeated-measures design (i.e., post- versus pre-intervention): Becker’s d [1-3]

,
Note. c(n−1)=Correction factor for small sample size bias and baseline differences, where n=the number
of participants post-intervention for the exercise or control group. 𝑌̅Post; Pre=Mean blood pressure for the
sample taken at post- and pre-intervention. Spre=Standard deviation of the pre-intervention blood pressure
for the exercise or control group.
3. The unstandardized mean difference ES estimate for two independent groups (i.e., parallel study
design; between-group ES) with a repeated-measures design (i.e., post- versus pre-intervention)
provided in the raw metric (mmHg) [2-4]:
E
E
C
C
̅ Post
̅ Pre
̅ Post
̅ Pre
) ─ (Y
)] , weighted by the inverse variance of the
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷 = [(Y
‒Y
‒Y

𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷:

, where

Note. UMD=Unstandardized mean difference. 𝑌̅Post − 𝑌̅Pre=Difference in blood pressure (mmHg) taken at
post- and pre-intervention for the Exercise (E) and Control (C) groups.
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1
𝑉𝑎𝑟𝑈𝑀𝐷

=Inverse variance of the

UMD. nE=number of participants in the exercise group post-intervention. nC=number of participants in
the control group post-intervention. Spooled=Pooled standard deviation. SE=Standard deviation of the postintervention blood pressure for the exercise group. SC=Standard deviation of the post-intervention blood
pressure for the control group.
4. The unstandardized mean difference ES estimate for a one-group (i.e., cross-over study design;
within-group ES) repeated-measures design (i.e., post- versus pre-intervention) provided in the raw
metric (mmHg) [2-4]:
̅ Post ‒ Y
̅ Pre )] , weighted by the inverse variance of the
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷 = [(Y
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷:

1
VarUMD

=

n
Spost (n)

Note. UMD=Unstandardized mean difference. 𝑌̅Post − 𝑌̅Pre=Difference in the sample’s blood pressure
(mmHg) taken at post- and pre-intervention. n=number of participants post-intervention.

1
𝑉𝑎𝑟𝑈𝑀𝐷

=Inverse

variance of the UMD. Spost=Standard deviation of the sample’s post-intervention blood pressure.
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Appendix 9. Summary of resting and ambulatory blood pressure assessment
techniques pre- and post-intervention (k=90).
Assessment Technique
k
Mean ± sd
Range
BP Assessment Procedures
56
62.2%
Gold Standard Followed
10
11.1%
—
Some Procedures Disclosed
46
51.1%
—
No Procedures Disclosed
34
37.8%
—
Timing of BP Measurements
59
65.6%
Pre-intervention: Seated or supine rest preceding
55
13.3 ± 10.5
3.0, 60.0
baseline reading (minutes)
Post-intervention: duration (hours) between last
15
67.2 ± 44.4
24.0, 168.0
exercise bout and post-BP reading
Less than 48 hours
2
30.0 ± 8.5
24.0, 36.0
≥48 to 96 hours
10
51.6 ± 11.4
48.0, 84.0
≥96 hours
3
144.0 ± 41.6
96.0, 168.0
—
Body Position
65
72.2%
Seated
44
67.7%
—
Supine
21
32.3%
—
—
BP Monitor/Assessment Tool
68
75.6%
Manual sphygmomanometer
36
52.9%
—
Random-zero
10
14.7%
—
Mercury
17
25.0%
—
“Standard aneroid”
9
13.2%
—
Automated
21
30.9%
—
Semi-automated/oscillometric device
11
16.2%
—
—
Ambulatory BP Monitoring
9
13.2%
Ambulatory BP Monitoring Period (hours)
9
19.3 ± 5.9
8.0, 24.0
24-Hour *
4
44.4%
—
Awake/Daytime †
8
9.9 ± 3.9
6.0, 16.0
Sleep/Nighttime ‡
6
11.8 ± 3.8
7.0, 16.0
Note. k=number of interventions. Statistics are presented as Mean ± Standard deviation (sd)
unless otherwise stated; Range=Minimum, Maximum. BP=Blood pressure. * 24-Hour [18,
55, 73]; 3 trials reported 24-hour ambulatory BP monitoring; yet BP data was collected over
22 [40] and 18 hours [43, 79]. † Daytime (“awake”) hours [7, 12, 18, 40, 43, 55, 79].
‡ Nighttime (“sleep”) hours [40, 43, 55, 79]; Gilders et al. [18] reported ABP data in three 8
hour segments (daytime, evening, nighttime); evening and nighttime were combined.
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Appendix 11. Figure S1. Tests for publication bias: Unadjusted Begg and Egger funnel plots
and adjusted funnel plot (via trim and fill procedures).
Note. Data points in the unadjusted plots are weighted and sized proportional to the inverse variance.
Systolic blood pressure: Aerobic exercise training versus non-exercise control:
Unadjusted Begg and Egger Plots:
Begg's funnel plot with pseudo 95% confidence limits
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8

Adjusted Funnel Plot (Trim and Fill): 7 iterations “trimmed” and the “filled” analysis was
based on k=120 versus k=105 comparisons
Filled funnel plot with pseudo 95% confidence limits
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Diastolic blood pressure: Aerobic exercise training versus non-exercise control
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Begg's funnel plot with pseudo 95% confidence limits
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Appendix 16. A summary of the dynamic resistance training intervention
characteristics (k=71).
Program Characteristics
k
Mean ± sd
Range
Median
15.0
Participants (n) at baseline
71
21.1 ± 14.9
8.0, 72.0
14.0
Participants (n) post-RT
71
18.4 ± 11.4
8.0, 60.0
0.0
Attrition in RT group (%)
71
8.5 ± 13.1
0.0, 53.0
Exercise Adherence (%)
46
92.3 ± 8.9
60.0, 100.0
95.0
Dynamic RT Program
12.0
Length (weeks)
71
14.4 ± 7.9
6.0, 48.0
-1
3.0
Frequency (days·week )
71
2.8 ± 0.6
2.0, 5.0
70.0
* Intensity or Load (% 1-RM)
63
67.2 ± 12.4
30.0, 100.0
3.8
† Estimated MET
71
4.7 ± 1.8
2.8, 8.5
65.0
Percentage of 1-RM (%)
38
64.7 ± 13.0
30.0, 87.5
MVC (%)
2
90.0 ± 14.4
80.0, 100.0
10-15 RM
8
12.6%
8-12 RM
8
12.5%
6-16 RM
2
3.1%
OMNI-RT Scale
2
3.1%
Theraband (not specified)
3
4.7%
-1
Time (total work∙session )
7.0
Number of exercises∙session-1
69
7.9 ± 2.9
1.0, 16.0
-1
3.0
Number sets∙exercise
67
2.8 ± 0.9
1.0, 5.0
-1
10.0
Number reps∙set
65
11.0 ± 3.8
5.0, 30.0
90.0
Rest interval between sets (s)
30
96.3 ± 43.3
15.0, 180.0
Type of RT
Conventional RT
54
76.0%
Circuit-style RT
10
14.3%
Therabands (i.e., elastic bands)
4
5.7%
Ankle or shin weights
2
2.9%
Muscle Groups Targeted
Upper and Lower Body
63
91.3%
Lower Body
4
5.8%
Unilateral, Upper Body
2
2.9%
Note. k=number of observations. Abbr. MVC=Maximum voluntary contraction. MET=
Metabolic equivalent unit. Range=Minimum, Maximum values. Reps=Repetitions. RM=
Repetition maximum. RT=Resistance training. s=seconds. %=Percentage. * When RT
load was reported as MVC or 1-RM range, % of 1-RM was estimated and combined with
trials that reported 1-RM (%). † When RT was unreported (k=12) or quantified in other
units (k=39), % of 1-RM was estimated using a standardized unit (i.e., MET).
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Appendix 17. Summary of the resting blood pressure assessment techniques pre-and
post-intervention (k=71).
Assessment Technique
k
Mean ± sd
Range
—
BP Assessment Procedures
49
69.0%
Gold Standard Followed
12
16.9%
—
Some Procedures Disclosed
37
52.1%
—
No Procedures Disclosed
22
31.0%
—
Timing of BP Measurements
Pre-intervention: Seated or supine rest
37
10.3 ± 5.5
5.0, 25.0
preceding baseline reading (min)
Post-intervention: duration (hr) between last
14
79.9 ± 59.1
20.0, 192.0
exercise bout and post-BP reading
Less than 24 hr
4
21.5 ±1.0
20.0, 22.0
24 to 48 hr
3
48.0 ± 0.0
—
>48 to 96 hr
2
84.0 ± 17.0
72.0, 96.0
>96 hr
5
144.0 ± 44.1
108.0, 192.0
—
Body Position
49
69.0%
Seated
30
61.2%
—
Supine
19
38.8%
—
Number of BP Readings
43
3.1 ± 1.1
2.0, 6.0
—
BP Monitor/ Assessment Tool
58
81.7%
Manual sphygmomanometer
29
40.8%
—
Random-zero
3
5.2%
—
Mercury
11
19.0%
—
“Standard aneroid”
15
25.9%
—
Automated
16
27.6%
—
Semi-automated/oscillometric device
13
22.4%
—
Ambulatory BP Monitor
2
4.1%
—
Note. k=number of observations. Statistics are presented as Mean ± Standard deviation
(sd) unless otherwise stated; Range=Minimum, Maximum. BP=Blood pressure.
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Appendix 19. Figure S3. Tests for publication bias: Funnel plots using Begg and Egger
methods. Note. Data points are weighted and sized proportional to the inverse variance.

Systolic blood pressure: Dynamic resistance training versus non-exercise control
Begg's funnel plot with pseudo 95% confidence limits
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Diastolic blood pressure: Dynamic resistance training versus non-exercise control
Begg's funnel plot with pseudo 95% confidence limits
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Appendix 20. Figure S4. Contour-enhanced funnel plots (i.e., confunnels): A visual
representation of the effect size distribution (the standardized mean difference, d+) for the
antihypertensive effects of dynamic resistance training versus non-exercise control.
Systolic Blood Pressure

Diastolic Blood Pressure

Note. Weighted mean effect size values (d+) are negative when dynamic resistance training reduced
blood pressure to a greater extent than control. The blue line and arrowhead indicates the overall
mean effect size.
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